EOS Med Chem Impurity Stock 20201029-1

 

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

Zuclopenthixol Decanoate, CAS: 64053-00-5, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₃ClN₂O₂S.

Zuclopenthixol Decanoate-d19, CAS: /, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₄D₁₉ClN₂O₂S.

Zuclopenthixol Decanoate-d4, CAS: /, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₉D₄ClN₂O₂S.

Zonisamide N,N-Dimethylformimidamide, CAS: 1217201-89-2, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₃S.

Zonisamide-N-(6-hexanoic Acid), CAS: 1076199-51-3, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₅S.

(7-Oxo-6-(pyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl) carbonic Acid Chloromethyl Ester, CAS: /, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉ClN₄O₄.

5-Chloro-2-pyridinamine, CAS: 1072-98-6, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅ClN₂.

5-Chloro-2-pyridinamine-3,4,6-d3, CAS: 1093384-99-6, stock: 1.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂D₃ClN₂.

7-Hydroxy-6-(pyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one, CAS: /, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈N₄O₂.

7-Hydroxy-furo[3,4-b]pyrazin-5-one, 70%, CAS: /, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₃.

Deschloro-Zopiclone, CAS: 1348046-61-6, stock: 4.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₆O₃.

Deschloro-Zopiclone-d3, CAS: /, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₈N₆O₃.

Zomepirac Acyl-O-β-D-glucuronide, CAS: 75871-31-7, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂ClNO₉.

Eszopiclone N-Oxide, CAS: 151851-70-6, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇ClN₆O₄.

Zomepirac Acyl-O-β-D-glucuronide 2-Propenyl Ester, CAS: 860615-41-4, stock: 8.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆ClNO₉.

Zomepirac Sodium Salt, CAS: 64092-48-4, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃ClNNaO₃.

Zomepirac Sodium Salt Hydrate, CAS: /, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃ClNNaO₃ •xH₂O.

Zomepirac Sodium Salt-d4, CAS: 85577-28-2, stock: 9.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₄ClNNaO₃.

RP 48497 (Eszopiclone Impurity C), CAS: 148891-53-6, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇ClN₄O.

(R)-(3-(2-(Dimethylamino)ethyl)-5,6,7,8-tetrahydro-1H-pyrrolo[3,2-g]isoquinolin-6-yl)methanol, CAS: /, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₃O.

(R)-(3-(2-(Dimethylamino)ethyl)-5,6-dihydro-1H-pyrrolo[3,2-g]isoquinolin-6-yl)methyl Acetate, CAS: /, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N₃O₂.

(S)-(9-(2-(Dimethylamino)ethyl)-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-h]isoquinolin-3-yl)methanol, CAS: /, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₃O.

(S)-(9-(2-(Dimethylamino)ethyl)-4,7-dihydro-3H-pyrrolo[2,3-h]isoquinolin-3-yl)methyl Acetate, CAS: /, stock: 6.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N₃O₂.

(S)-1-(9-(2-(Dimethylamino)ethyl)-3-(hydroxymethyl)-3,4-dihydro-1H-pyrrolo[2,3-h]isoquinolin-2(7H)-yl)ethanone, CAS: /, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₃O₂.

(S)-3-(3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)-2-formamidopropyl Acetate, CAS: /, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₃O₃.

(S)-4-((2-Methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-6-yl)methyl)oxazolidin-2-one, CAS: /, stock: 5.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉N₃O₂.

(S)-N-(1-(3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)-3-hydroxypropan-2-yl)formamide, CAS: /, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₃O₂.

N4-Methylene Zolmitriptan, CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁N₃O₂.

2-(2-(3-Bromo-4-methylphenyl)-6-methylimidazo[1,2-a]pyridin-3-yl)acetic Acid, CAS: /, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅BrN₂O₂.

2-(3-Bromo-4-methylphenyl)-6-methylimidazo[1,2-a]pyridine, CAS: /, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃BrN₂.

2-Bromo-1-(3-bromo-4-methylphenyl)ethanone, CAS: 60208-05-1, stock: 5.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈Br₂O.

2-Keto Zolpidem, CAS: 400038-68-8, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉N₃O₂.

2-Keto Zolpidem-d6, CAS: 1330165-18-8, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₃D₆N₃O₂.

2-[4-(Ethoxycarbonyl)phenyl]-6-methyl-imidazo[1,2-a]pyridine-3-acetic Acid, CAS: 1025962-20-2, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₄.

3-Bromo Zolpidem, CAS: /, stock: 5.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀BrN₃O.

5-Methyl Zolpidem, CAS: 1346600-85-8, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁N₃O.

6-(Methoxycarbonyl)-2-(4-methylphenyl)imidazo[1,2-a]pyridine, CAS: 917252-78-9, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂O₂.

6-(Methoxycarbonyl)-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetic Acid,, CAS: 917252-80-3, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₂O₄.

6-Methyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine, CAS: 88965-00-8, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂.

6-Methyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-d6, CAS: 959605-52-8, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₆N₂.

6-Methyl-2-(4-methylphenyl)-α-oxo-imidazo[1,2-a]pyridine-3-acetic Acid Ethyl Ester, CAS: 388633-49-6, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₃.

6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide, CAS: 365213-58-7, stock: 4.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₃O.

Desmethylphenyl-methyl Zolpidem N-Oxide, CAS: /, stock: 9.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₃O₂.

Desmethylphenyl-methyl Zolpidem-d6 N-Oxide, CAS: /, stock: 6.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₆N₃O₂.

Ethyl 2-(2-(3-Bromo-4-methylphenyl)-6-methylimidazo[1,2-a]pyridin-3-yl)acetate, CAS: /, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉BrN₂O₂.

α-Hydroxyzolpidem, CAS: 118026-14-5, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁N₃O₂.

N,N-Dimethyl 3-Bromo-4-(4-methylphenyl)-4-oxobutanamide, CAS: 836627-56-6, stock: 7.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆BrNO₂.

N,N-Dimethyl-4-oxo-4-(p-tolyl)butanamide, CAS: 402470-91-1, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₂.

Zolpidem 6-Carboxylic Acid, CAS: 109461-15-6, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉N₃O₃.

Zolpidem 6-Carboxylic Acid Methyl Ester, CAS: 917252-81-4, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁N₃O₃.

Zolpidem Carbaldehyde, CAS: 400777-11-9, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂O.

Zolpidem Carbaldehyde-d6, CAS: 1329611-32-6, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈D₆N₂O.

Zolpidem IV, CAS: 768398-03-4, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₃.

Zolpidem IV-d6, CAS: /, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉D₆N₃.

Zolpidem-d6 6-Carboxylic Acid, CAS: 1190014-62-0, stock: 7.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₃D₆N₃O₃.

Zolpidem-d6 6-Carboxylic Acid Methyl Ester, CAS: 1215767-20-6, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₆N₃O₃.

1,3-Bis(2-hydroxy-2,2-diphosphonoethyl)-imidazolium Soidum Salt (1:7)(Zoledronic Acid Impurity), CAS: /, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₂Na₇O₁₄P₄.

1,3-Bis(carboxymethyl)-1H-imidazolium, CAS: 117255-11-5, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₄.

Zoledronic Acid Disodium Salt Tetrahydrate, CAS: 165800-07-7, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₂Na₂O₇P₂•4H₂O.

(2S,4S)-4-(Phenylthio)-1,2-pyrrolidinedicarboxylic-d5 Acid 1-(1,1-Dimethylethyl) Ester, CAS: /, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₅NO₄S.

(2S,4S)-4-(Phenylthio)-1,2-pyrrolidinedicarboxylic-d5 Acid 1-tert-Butyl-2-Methyl Diester, CAS: /, stock: 4.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₅NO₄S.

(4S)-4-(Phenylthio)-L-proline Hydrochloride, CAS: 105107-84-4, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClNO₂S.

(4S)-4-(Phenylthio)-L-proline-d5 Hydrochloride, CAS: /, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₅ClNO₂S.

Zofenopril Acyl-β-D-glucuronide, CAS: /, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁NO₁₀S₂.

Zofenoprilat Acyl-β-D-glucuronide, CAS: /, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₉S₂.

Zofenoprilat N-Ethyl Succinimide, CAS: 1217526-22-1, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₅S₂.

Zofenoprilat Sodium Salt (90%), CAS: 1329569-13-2, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈NNaO₃S₂.

Zofenoprilat-d5, CAS: 1217716-12-5, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₅NO₃S₂.

Zofenoprilat-d5 N-Ethyl Succinimide, CAS: 1217546-60-5, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₅N₂O₅S₂.

2-[5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-4-chloro-2-nitrophenyl]-propanedioic Acid 1,3-Dimethyl Ester, CAS: 160384-39-4, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅ClN₄O₆S.

3-(1,2-Benzisothiazolyl) Ziprasidone(Ziprasidone Impurity E), CAS: 1159977-04-4, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄ClN₅OS₂.

3-(1-Piperazinyl)-1,2-benzisothiazole 1-Oxide, CAS: 128396-56-5, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃OS.

3-[4-[2-(2,5-Dichloro-4-nitrophenyl)ethenyl]-1-piperazinyl]-1,2-benzisothiazole, CAS: 160384-37-2, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆Cl₂N₄O₂S.

3-[4-[2-(2,5-Dichloro-4-nitrophenyl)ethyl]-1-piperazinyl]-1,2-benzisothiazole, CAS: 160384-38-3, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈Cl₂N₄O₂S.

5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-4-chloro-2-nitro-benzeneacetic Acid, CAS: 160384-40-7, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁ClN₄O₄S.

Ziprasidone Amino Acid Sodium Salt(Ziprasidone Impurity C), CAS: 1798033-44-9, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂ClN₄NaO₂S.

Ziprasidone Free Base, CAS: 146939-27-7, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁ClN₄OS.

Ziprasidone Sulfoxide, CAS: 188797-80-0, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁ClN₄O₂S.

4,5-Dihydro-6-oxime-imidazo[4,5,1-jk][1]benzazepine-2,6,7(1H)-trione, CAS: 92260-82-7, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉N₃O₃.

6-Amino-5,6-dihydroimidazo[4,5,1-jk][1]benzazepine-2,7(1H,4H)-dione, CAS: 1019769-46-0, stock: 1.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O₂.

Desisopropyl Zilpaterol Hydrochloride, CAS: 92260-83-8, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClN₃O₂.

Zilpaterol, CAS: 119520-05-7, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₂.

Zilpaterol-13C3, CAS: /, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³C₃H₁₉N₃O₂.

Zilpaterol-d7, CAS: 1217818-36-4, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₇N₃O₂.

(E)-1-(Benzo[b]​thiophen-​2-​yl)ethanone Oxime, CAS: /, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NOS.

(Z)-1-(Benzo[b]​thiophen-​2-​yl)ethanone Oxime, CAS: /, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NOS.

Hydroxy 1-(Phenylsulfonyl)ethylcarbamic acid 1,1-Dimethylethyl Ester, CAS: 870300-77-9, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₅S.

Zileuton β-D-Glucuronide, CAS: 141056-63-5, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O₈S.

3-(3-Azido-2,3-dideoxy-β-D-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione, CAS: 123606-70-2, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅O₄.

Cetalkonium Chloride, CAS: 122-18-9, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₆ClN.

Zephirol, CAS: 139-07-1, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₈ClN.

Zephirol-d7, CAS: /, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁D₇ClN.

2”-Deoxy-Zebularine 5’Phosphate, CAS: /, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₂Na₂O₇P.

α-2’-Deoxy Zebularine, CAS: 68780-64-3, stock: 4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄.

β-2’-Deoxy Zebularine, CAS: 22003-30-1, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄.

β-2’-Deoxy Zebularine-13C,15N, CAS: /, stock: 6.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂¹⁵N₂O₄.

Zebularine CEP, CAS: 155831-90-6, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₁N₄O₈PSi.

2-Methylthio-cis-zeatin Riboside, CAS: 52049-48-6, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₅O₅S.

2-Methylthio-trans-zeatin (2MeStZ), CAS: 29736-33-2, stock: 5.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₅OS.

6-[(E)-4-Hydroxy-3-methylbut-2-enylamino]-9-β-D-ribofuranosylpurine, CAS: 6025-53-2, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N₅O₅.

6-[(E)-4-Hydroxy-3-methylbut-2-enylamino]-9-β-D-ribofuranosylpurine-d5, CAS: 72963-21-4, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆D₅N₅O₅.

cis-Zeatin, CAS: 32771-64-5, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅O.

cis-Zeatin-9-glucoside (cZ9G), CAS: 169565-72-4, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₅O₆.

cis-Zeatin-O-glucoside (cZOG), CAS: 71866-93-8, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₅O₆.

Dihydrozeatin, CAS: 175733-30-9, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂D₃N₅O.

Dihydrozeatin O-Glucoside, CAS: 62512-96-3, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅N₅O₆.

Dihydrozeatin Riboside, CAS: 175733-31-0, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀D₃N₅O₅.

Dihydrozeatin Riboside, CAS: 22663-55-4, stock: 6.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N₅O₅.

R-(-)-Dihydrozeatin Riboside, CAS: 64070-21-9, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N₅O₅.

S-(-)-Dihydrozeatin Riboside, CAS: 64070-22-0, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N₅O₅.

trans-Zeatin, CAS: 1637-39-4, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅O.

trans-Zeatin Hydrochloride, CAS: 6025-81-6, stock: 9.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅O•HCl.

trans-Zeatin Riboside-5‘-monophosphate Disodium Salt (tZRMP), CAS: 174063-91-3, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₅Na₂O₈P.

trans-Zeatin-13C,d2, CAS: 1287206-71-6, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³CH₁₁D₂N₅O.

trans-Zeatin-7-glucoside, CAS: 38165-56-9, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₅O₆.

trans-Zeatin-9-glucoside, CAS: 51255-96-0, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₅O₆.

trans-Zeatin-9-glucoside-d5, CAS: 84744-92-3, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₅N₅O₆.

trans-Zeatin-O-acetyl (ActZ), CAS: 6025-82-7, stock: 9.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₅O₂.

trans-Zeatin-O-glucoside, CAS: 72963-23-6, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₅N₅O₆.

trans-Zeatin-O-glucoside (cZOG), CAS: 56329-06-7, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₅O₆.

trans-Zeatin-O-glucoside Riboside-d5, CAS: 69700-29-4, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆D₅N₅O₁₀.

Zeatin, CAS: 13114-27-7, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅O.

Zeatin Riboside, CAS: 28542-78-1, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N₅O₅.

(2Z,4E)-3-Methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)penta-2,4-dienenitrile, CAS: 1155402-76-8, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N.

(3R)-3-Hydroxy-β-ionone, CAS: 50281-38-4, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀O₂.

Zeaxanthin Diacetate, CAS: 16638-61-2, stock: 3.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₆₀O₄.

(R)-Zearalenone, CAS: 1394294-92-8, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂O₅.

(S)-Zearalanone, CAS: 5975-78-0, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄O₅.

rac Zearalanone-d6, CAS: 1795020-90-4, stock: 1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈D₆O₅.

Zearalenone 4-Sulfate Ammonium Salt, CAS: 1439328-85-4, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO₈S.

Zearalenone Disulfate Diammonium Salt, CAS: 1439329-55-1, stock: 3.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O₁₁S₂.

α-Zearalenol, CAS: 36455-72-8, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄O₅.

α-Zearalenol-d4 (Major), CAS: 1778734-73-8, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀D₄O₅.

α-Zearalenol-d7, CAS: /, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₇O₅.

β-Zearalenol, CAS: 71030-11-0, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄O₅.

β-Zearalenol-d4 (Major), CAS: 1778735-09-3, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀D₄O₅.

β-Zearalenol-d7, CAS: /, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₇O₅.

2-Chloroethyl Isothiocyanate, CAS: 6099-88-3, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄ClNS.

4-N-tert-Butyloxycarbonyl Zanamivir Amine, CAS: 166830-74-6, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆N₂O₉.

N-Cyano Zanamivir Amine Triacetate Methyl Ester, CAS: 1228216-82-7, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅N₃O₁₀.

Zanamivir, CAS: 139110-80-8, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₄O₇.

Zanamivir Amine, CAS: 130525-62-1, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂O₇.

Zanamivir Amine Triacetate Methyl Ester, CAS: 139110-70-6, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆N₂O₁₀.

Zanamivir Azide Methyl Ester, CAS: 152178-79-5, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₄O₇.

Zanamivir Azide Triacetate Methyl Ester, CAS: 130525-58-5, stock: 3.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₄O₁₀.

Zanamivir-13C,15N2, CAS: 1276528-62-1, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₂₀N₂¹⁵N₂O₇.

2-(3-(Carboxymethyl)-4-(phenylthio)-phenyl)propanoic Acid, CAS: 83237-49-4, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆O₄S.

Zaltoprofen, CAS: 74711-43-6, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O₃S.

Zaltoprofen β-D-Glucuronide, CAS: /, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂O₉S.

Zaltoprofen Sulfoxide, CAS: 134085-79-3, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O₄S.

Zaltoprofen-d7, CAS: /, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₇D₇O₃S.

Zaltoprofen-d7 β-D-Glucuronide, CAS: /, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₅D₇O₉S.

Zaltoprofen-d7 Sulfoxide, CAS: /, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₇D₇O₄S.

(E)-N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-ethylacetamide, CAS: 1227694-96-3, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O₂.

(E)-N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-ethylacetamide-d5, CAS: 1104483-92-2, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅D₅N₂O₂.

(E)-N-(3-(3-(Dimethylamino)acryloyl)phenyl)acetamide, CAS: 1227694-86-1, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₂.

1,1-Dimethylethyl 5-Amino-4-cyano-1H-pyrazole-1-carboxylic Acid Ester, CAS: 1232792-00-5, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₄O₂.

2-(2-(3-(N-Ethylacetamido)phenyl)-1,3-dioxolan-2-yl)acetic Acid, CAS: /, stock: 1.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₅.

3-(Acetylethylamino)-β-oxo-benzenepropanoic Acid Ethyl Ester, CAS: 1796965-05-3, stock: 5.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₄.

3-(Acetylethylamino)-β-oxo-benzenepropanoic Acid Ethyl Ester-d5, CAS: /, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₅NO₄.

3-Amino-1H-pyrazole-4-carboxylic Acid, CAS: 41680-34-6, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O₂.

3-Bromo-β-oxo-benzenepropanal Sodium Salt, CAS: 933054-29-6, stock: 9.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrNaO₂.

5-Oxo-ZaleplonDISCONTINUED. Please see C979513., CAS: 159225-99-7, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₅O₂.

5-Oxo-Zaleplon-d5DISCONTINUED. Please see C979514., CAS: /, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₅N₅O₂.

6-Chloro-pyrazolo[1,5-a]pyrimidine-3-carboxylic Acid, CAS: 1204926-24-8, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄ClN₃O₂.

6-Iodo-pyrazolo[1,5-a]pyrimidine-3-carboxylic Acid, CAS: /, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄IN₃O₂.

6-Methoxy-pyrazolo[1,5-a]pyrimidine-3-carboxylic Acid, CAS: 1356016-93-7, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O₃.

6-Methyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic Acid, CAS: 869941-96-8, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O₂.

Ethyl 2-(2-(3-(N-Ethylacetamido)phenyl)-1,3-dioxolan-2-yl)acetate, CAS: /, stock: 8.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₅.

Ethyl trans-3-Ethoxyacrylate, CAS: 5941-55-9, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₃.

N-(3-(3-Cyano-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)phenyl)-N-(ethyl-d5)acetamide, CAS: /, stock: 3.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₅N₅O₂.

N-(3-(3-Cyano-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)phenyl)-N-ethylacetamide, CAS: /, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₅O₂.

N-(3-(3-Cyanopyrazolo[1,5-α]pyrimidin-5-yl)phenyl)-N-ethylacetamide, CAS: 478081-98-0, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₅O.

N-(3-Acetylphenyl)-N-ethylacetamide, CAS: 200630-96-2, stock: 4.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂.

N-(3-Acetylphenyl)-N-ethylacetamide-d5, CAS: /, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀D₅NO₂.

N-(3-Acetylphenyl)formamide, CAS: 72801-78-6, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

N-(4-Cyano-1H-pyrazol-5-yl)-3-(3-(N-ethylacetamido)phenyl)-3-oxopropanamide, CAS: /, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₅O₃.

N-[3-(3-Cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]acetamide, CAS: 115931-01-6, stock: 3.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁N₅O.

N-[3-(3-Dimethylaminoacryloyl)phenyl]-N-ethylacetamide, CAS: 96605-66-2, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O₂.

N-[3-(3-Dimethylaminoacryloyl)phenyl]-N-ethylacetamide-d5, CAS: 1104483-92-2, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅D₅N₂O₂.

N-[3-(3-Dimethylaminoacryloyl)phenyl]acetamide, CAS: 96605-61-7, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₂.

N-[3-[(2E)-3-(Dimethylamino)-1-oxo-2-propen-1-yl]phenyl]-formamide, CAS: 1227694-91-8, stock: 6.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₂.

N-[3-[(2E)-3-(Dimethylamino)-1-oxo-2-propen-1-yl]phenyl]-N-ethyl-formamide, CAS: 1227694-93-0, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₂.

tert-Butyl 4-Cyano-5-(2-(2-(3-(N-ethylacetamido)phenyl)-1,3-dioxolan-2-yl)acetamido)-1H-pyrazole-1-carboxylate, CAS: /, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₅O₆.

Zaleplon (1.0 mg/mL in Methanol), CAS: 151319-34-5, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₅O.

Zaleplon Formamide, CAS: 1227694-78-1, stock: 7.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃N₅O.

Zaleplon-d5, CAS: 1001083-56-2, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₅N₅O.

((2S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Phosphorodiamidate, CAS: /, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₅O₄P.

Zalcitabine, CAS: 7481-89-2, stock: 10g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₃.

Zalcitabine Monophosphate Ammonium Salt, CAS: 1179343-05-5, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₄O₆P.

Zalcitabine Monophosphate Sodium Salt, CAS: 104086-76-2, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃NaO₆P.

Zalcitabine Triphosphate Trisodium Salt, CAS: /, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃Na₃O₁₂P₃.

Zalcitabine-13C,15N2, CAS: /, stock: 2.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₃N¹⁵N₂O₃.

17alpha-Hydroxy-yohimban-16alpha-carboxylic Acid Methyl Ester, CAS: 146-48-5, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₃.

2,3-Dihydro-1,4-benzodioxin-2-carboximidic Acid Ethyl Ester Hydrochloride, CAS: 79944-55-1, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃ • HCl.

Isorauhimbin, CAS: 483-09-0, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₃.

Raubasine, CAS: 483-04-5, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄N₂O₃.

Yohimbine N,O-Methoxycarbonate, CAS: /, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀N₂O₇.

2-Chloro Zafirlukast, CAS: /, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂ClN₃O₆S.

2-Chloro Zafirlukast-d7, CAS: /, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₅D₇ClN₃O₆S.

2-[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl] Zafirlukast, CAS: 1160235-26-6, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₄₈N₄O₁₀S₂.

2-[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl] Zafirlukast-d3, CAS: /, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₄₅D₃N₄O₁₀S₂.

Decyclopentyl Zafirlukast Methyl Ester, CAS: 1159195-67-1, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇N₃O₆S.

Decyclopentyl Zafirlukast-d3 Methyl Ester, CAS: 1795011-90-3, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄D₃N₃O₆S.

Zafirlukast, CAS: 107753-78-6, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₃N₃O₆S.

Zafirlukast Impurity F, CAS: 1160235-28-8, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₉N₅O₈S.

Zafirlukast Impurity F-d7, CAS: /, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₂D₇N₅O₈S.

Zafirlukast Impurity G, CAS: 1391990-94-5, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₅.

Zafirlukast Impurity G-d7, CAS: /, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₅D₃N₄O₅.

Zafirlukast Impurity H, CAS: /, stock: 8.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇N₃O₄.

Zafirlukast Impurity H-d11, CAS: /, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆D₁₁N₃O₄.

Zafirlukast m-Tolyl Isomer, CAS: 1159195-69-3, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₃N₃O₆S.

Zafirlukast m-Tolyl Isomer-d7, CAS: 1794760-52-3, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₆D₇N₃O₆S.

1-Deoxy-D-xylulose (Aqueous Solution, 1 M), CAS: 60299-43-6, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₄.

Zafirlukast M5 Metabolite, CAS: 219582-82-8, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₃N₃O₇S.

Zafirlukast M6 Metabolite, CAS: 219582-85-1, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₃N₃O₇S.

Zafirlukast p-Tolyl Isomer, CAS: 1159195-70-6, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₃N₃O₆S.

Zafirlukast p-Tolyl Isomer-d7, CAS: 1794886-13-7, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₆D₇N₃O₆S.

Zafirlukast-d7, CAS: 1217174-18-9, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₆D₇N₃O₆S.

Bovine DCXR (L-xylulose reductase) ELISA Kit (96T), CAS: /, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

D-Xylulose (0.5 M in Water), CAS: 551-84-8, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₅.

D-Xylulose 5-Phosphate (~80%), CAS: 4212-65-1, stock: 8.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁O₈P.

D-Xylulose 5-Phosphate Sodium Salt, CAS: 105931-44-0, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀NaO₈P.

D-[1-13C]Xylulose (1M in Water), CAS: 131771-46-5, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.

D-[2-13C]Xylulose, CAS: 131771-47-6, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.

Dibenzyl ((2R,3R,4R)-2,3,5-Tris(benzyloxy)-4-hydroxypentyl) Phosphate, CAS: 2088844-78-2, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₃O₈P.

Dibenzyl ((2R,3S)-2,3,5-Tris(benzyloxy)-4-oxopentyl) Phosphate, CAS: 2088844-79-3, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₁O₈P.

L-Lyxose, CAS: 1949-78-6, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₅.

L-Lyxose-1-13C, CAS: /, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₄H₁₀O₅.

L-Lyxose-2-13C, CAS: /, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₄H₁₀O₅.

L-Lyxose-5-13C, CAS: /, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₄H₁₀O₅.

L-Xylulose (1.0 M in water), CAS: 527-50-4, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₅.

Mouse Dcxr (L-xylulose reductase) ELISA Kit (96T), CAS: /, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Dcxr (L-xylulose reductase) ELISA Kit (96T), CAS: /, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Xylazine, CAS: 7361-61-7, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂S.

Xylazine Hydrochloride, CAS: 23076-35-9, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇ClN₂S.

Xylazine-d6 Hydrochloride, CAS: 1795020-86-8, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₆ClN₂S.

1,3,5,8-Tetrahydroxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one, CAS: 33390-42-0, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄O₆.

1,5-Dibromopentane, CAS: 111-24-0, stock: 4.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀Br₂.

1,6-Dibromohexane, CAS: 629-03-8, stock: 5.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂Br₂.

2-(9-Oxoxanthen-2-yl)propionic Acid 1,8-Diazabicyclo[5.4.0]undec-7-ene Salt, CAS: 1346753-05-6, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₄ • C ₉H₁₆N₂.

2-Bromoxanthone, CAS: 56341-31-2, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₇BrO₂.

2-Chlorothioxanthone, CAS: 86-39-5, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₇ClOS.

2-Isopropyl Thioxanthone, CAS: 5495-84-1, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄OS.

2-Isopropyl-d7 Thioxanthone, CAS: 1173019-24-3, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₇D₇OS.

4-Isopropylthioxanthone, CAS: 83846-86-0, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄OS.

5-Bromo-3,4-dimethyl-9H-xanthen-9-one, CAS: 1035912-43-6, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁BrO₂.

8-Deoxygartanin, CAS: 33390-41-9, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄O₅.

9-Oxo-xanthene-2-carboxylic Acid Methyl Ester, CAS: 42946-50-9, stock: 6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O₄.

Atroviridin, CAS: 207984-34-7, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄O₆.

Gerontoxanthone C, CAS: 121825-54-5, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄O₆.

Gerontoxanthone C-d6, CAS: /, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈D₆O₆.

γ-Mangostin, CAS: 31271-07-5, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄O₆.

Mangiferin, CAS: 4773-96-0, stock: 1.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈O₁₁.

Mangostin, CAS: 01/11/6147, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆O₆.

Mangostin-d3, CAS: 1185047-73-7, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃D₃O₆.

Neomangiferin, CAS: 64809-67-2, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈O₁₆.

Phomoxanthone A, CAS: 359844-69-2, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₈O₁₆.

Thioxanthen-9-one, CAS: 492-22-8, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈OS.

2,6-Dihydro-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)purine, CAS: 61444-45-9, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₉.

2’-Deoxyxanthosine, CAS: 29049-22-7, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₄O₅.

5’-O-(4,4’-Dimethoxytrityl)-7-deaza-2’-deoxyxanthosine, CAS: 869355-16-8, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₁N₃O₇.

5’-Xanthylic Acid Triethylammonium Salt, CAS: /, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₃N₆O₉P.

5’-Xanthylic Acid-13C5  Disodium Salt, CAS: /, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₅H₁₁N₄Na₂O₉P.

6-[(4-Methylphenyl)thio]-2-oxo-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)-2,3-dihydropurine, CAS: 135041-24-6, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₄O₈S.

7-Deaza-2’-deoxyxanthosine, CAS: 96022-82-1, stock: 2.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₅.

9-(Trimethylsilyl)-2,6-bis[(trimethylsilyl)oxy]-9H-purine, CAS: 18551-03-6, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₈N₄O₂Si₃.

Decoyinin, CAS: 08/04/2004, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₅O₄.

Psicofuranine, CAS: 1874-54-0, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₅O₅.

Capsorubin, CAS: 470-38-2, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₆O₄.

rac Xanthophyll-d6, CAS: /, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₀D₆O₂.

Xanthophyll (~80%), CAS: 127-40-2, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₆O₂.

WAY 100635, CAS: 162760-96-5, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄N₄O₂.

WAY 100635 Hydrochloride, CAS: 146714-97-8, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇Cl₃N₄O₂.

WAY 100635-d11 Hydrochloride, CAS: /, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆D₁₁Cl₃N₄O₂.

WST-1, CAS: 150849-52-8, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₁IN₅NaO₈S₂.

WST-3, CAS: 515111-36-1, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₀IN₆NaO₁₀S₂.

WST-8, CAS: 193149-74-5, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃N₆NaO₁₁S₂.

WST-8, CAS: 193149-74-5, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄N₆O₁₁S₂ • Na.

(3S,3’S,5R,5’R,6R,6’S,9’-cis)-6,7-Didehydro-5’,6’-epoxy-5’,6’-dihydro-β,​β-carotene-3,3’,5(6H)-triol Solution in Ethanol, CAS: 14660-91-4, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₆O₄.

(6R)-5,6,7,8-Tetrahydro-L-biolumazine, CAS: /, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₄O₄.

1,3,7,8-Tetramethylzanthine, CAS: 832-66-6, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₄O₂.

1,3,7,9-Xanthinium Perchlorate, CAS: 17749-99-4, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃ClN₄O₆.

1,3-Dibutylxanthine, CAS: 2850-36-4, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₄O₂.

1,3-Diethyl-8-phenylxanthine, CAS: 75922-48-4, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₄O₂.

1,3-Dipropyl-8-p-sulfophenylxanthine, CAS: 89073-57-4, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₄O₅S.

1,3-Dipropyl-8-phenylxanthine, CAS: 85872-53-3, stock: 1.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₄O₂.

1,7-Dimethylxanthine (paraxanthine, 2,4,5,6-13C4 1,3,9-15N3), CAS: 1173018-79-5, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₄H₈N¹⁵N₃O₂.

1,7-Dimethylxanthine (Paraxathine, Dimethyl-d6), CAS: 117490-41-2, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂D₆N₄O₂.

1-Allyl-3,7-dimethyl-8-p-sulfophenylxanthine Sodium Salt, CAS: 249929-56-4, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₄NaO₅S.

1-Allyl-3,7-dimethyl-8-phenylxanthine, CAS: 149981-23-7, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₄O₂.

1-Allyl-3,7-dimethyl-8-phenylxanthine-d5, CAS: /, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₅N₄O₂.

1-Bromo-3-methyl-2-butene (90%), CAS: 870-63-3, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉Br.

1-Methyl Xanthine, CAS: 6136-37-4, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₂.

1-Methyl Xanthine-d3, CAS: 1216430-61-3, stock: 3.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃D₃N₄O₂.

2,3-Dichlorobenzoyl chloride, CAS: 2905-60-4, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃Cl₃O.

2,3-Dichlorobenzoyl Chloride-13C,D3, CAS: /, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³CD₃Cl₃O.

2,4-Dihydroxypyrrolo[2,3-d]pyrimidine, CAS: 39929-79-8, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₃O₂.

2-Acetamido-4-methylthiazole, CAS: 7336-51-8, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂OS.

2-Cyano-N-((furan-2-ylmethyl)carbamoyl)acetamide, CAS: /, stock: 1.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃O₃.

2’,3’,5’-Tri-O-benzoyl Xanthine-13C5, CAS: /, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆¹³C₅H₂₄N₄O₉.

2’-Deoxyguanosine N1-(Ethyl Acrylate), CAS: 895571-80-9, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₅O₆.

3,7-Dimethyl-1-propargylxanthine, CAS: 14114-46-6, stock: 9.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₄O₂.

3,7-Dimethyl-8-(p-sulfonamidophenyl)xanthine, CAS: 149981-21-5, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₅O₄S.

3,7-Dimethyl-8-p-sulfophenylxanthine, CAS: 149981-20-4, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₄O₅S.

3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,5-dihydropyrimido[1,2-a]purine-6,10-dione, CAS: 895571-79-6, stock: 4.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₅O₅.

3-Aminopiperidine Dihydrochloride, CAS: 138060-07-8, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂ • 2(HCl).

3-Isobutyl-1-methylxanthine, CAS: 28822-58-4, stock: 2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₄O₂.

3-Methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tertbutyloxycarbonylamino)piperidin-1-yl]-xanthine, CAS: 666816-91-7, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈N₆O₄.

3-Methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tertbutyloxycarbonylamino)piperidin-1-yl]-xanthine-d3, CAS: /, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₃N₆O₄.

3-Methyl-7-(5-oxohexyl)-1-propylxanthine, CAS: 55242-58-5, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₄O₃.

3-Methyl-7-propylxanthine, CAS: 55242-64-3, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₄O₂.

4-Amino-5-formylamino-3-isobutyl-1-methylpyrimidine-2,6-dione, CAS: 130332-59-1, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₄O₃.

4-Amino-6-hydroxypyrazolo[3,4-d]pyrimidine, CAS: 5472-41-3, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₅O.

4-Chlorostyrene, CAS: 1073-67-2, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇Cl.

4-Fluorobenzeneacetic Acid, CAS: 405-50-5, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇FO₂.

4-{3H-Imidazo[4,5-c]pyridin-2-yl}aniline, CAS: 75007-95-3, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₄.

5,5-Dimethyl-1-pyrroline N-Oxide, CAS: 3317-61-1, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO.

5-Amino-3,7-dimethyl Xanthine-d6, CAS: 1185126-58-2, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃D₆N₅O₂.

5-Amino-3,7-dimethylxanthine, CAS: 81281-47-2, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₅O₂.

6-(((1,3-Dioxolan-2-yl)methyl)amino)-1,3-dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione, CAS: /, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₄O₆.

6-(((1,3-Dioxolan-2-yl)methyl)amino)-5-amino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, CAS: /, stock: 4.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₄O₄.

6-Amino-1,3-dibutyl-5-nitroso-2,4(1H,3H)-pyrimidinedione, CAS: 132716-86-0, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₄O₃.

6-Amino-1-(2-furanylmethyl)-3-methyl-2,4(1H,3H)-pyrimidinedione, CAS: 82593-39-3, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₃O₃.

6-Amino-1-ethyl-3-propyl-2,4(1H,3H)-pyrimidinedione, CAS: 63981-31-7, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N₃O₂.

7-(β-Hydroxypropyl)theophylline, CAS: 603-00-9, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₄O₃.

7-Ethyl Theophylline, CAS: 23043-88-1, stock: 8.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₄O₂.

8(-p-Sulfophenyl)theophylline, CAS: 80206-91-3, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₄O₅S.

8-((-2-Acetylphenyl)amino)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione, CAS: /, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₅O₃.

8-Azaxanthine Monohydrate, CAS: 59840-67-4, stock: 8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₅O₃.

8-Bromo-3,7-dihydro-3-methyl-7-(1-methylethyl)-1H-purine-2,6-dione, CAS: 123980-53-0, stock: 2.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BrN₄O₂.

8-Bromo-3,7-dihydro-3-methyl-7-(1-methylethyl)-1H-purine-2,6-dione-d7, CAS: /, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₄D₇BrN₄O₂.

8-Bromo-3-methyl-d3-7-(2-butynyl)-xanthine, CAS: /, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆D₃BrN₄O₂.

8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione, CAS: 853029-57-9, stock: 2.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇BrN₆O₂.

8-Bromo-7-ethyl-3,7-dihydro-3-methyl-1H-purine-2,6-dione, CAS: 101071-96-9, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BrN₄O₂.

8-Bromo-7-ethyl-3,7-dihydro-3-methyl-1H-purine-2,6-dione-d5, CAS: /, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄D₅BrN₄O₂.

8-Bromoxanthine, CAS: 10357-68-3, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃BrN₄O₂.

8-Bromoxanthine-15N2,13C, CAS: /, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₃BrN₂¹⁴N₂O₂.

8-Chloro-1-methylxanthine, CAS: 6136-36-3, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₄O₂.

8-Chlorotheophylline, CAS: 85-18-7, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇ClN₄O₂.

8-Chlorotheophylline-d6, CAS: 1346598-95-5, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇HD₆ClN₄O₂.

8-Cyclopentyl-1,3-dimethylxanthine, CAS: 35873-49-5, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₄O₂.

8-Cyclopentyl-1,3-dipropylxanthine, CAS: 102146-07-6, stock: 8.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₄O₂.

8-Methoxymethyl-1-methyl-3-(2-methylpropyl) Xanthine, CAS: 78033-08-6, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₄O₃.

8-Methylxanthine, CAS: 17338-96-4, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₂.

9-​(1,​3-​Dioxolan-​2-​ylmethyl)​-​3,​9-​dihydro-​1,​3-​dimethyl-1H-​purine-​2,​6-​dione, CAS: 1174289-18-9, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₄O₄.

9-Methylxanthine, CAS: 1198-33-0, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₂.

all-trans-Canthaxanthin, CAS: 514-78-3, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₂O₂.

Aminophylline, CAS: 317-34-0, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₂  • 1/2 C ₂H₈N₂.

Asperulosidic Acid, CAS: 25368-11-0, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄O₁₂.

Doxofylline, CAS: 69975-86-6, stock: 7.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₄O₄.

Doxofylline-d4, CAS: 1346599-13-0, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₄N₄O₄.

Dyphylline, CAS: 479-18-5, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₄O₄.

Enprofylline, CAS: 41078-02-8, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₄O₂.

2-(3-Bromo-4-methoxyphenyl)-5,5-dimethyl-1,3-dioxane, CAS: 179942-58-6, stock: 2.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇BrO₃.

Etofylline, CAS: 519-37-9, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₄O₃.

5-(5,5-Dimethyl-1,3-dioxan-2-yl)-α-[5-(5,5-dimethyl-1,3-dioxan-2-yl)-2-methoxyphenyl]-2-methoxy-α-(4-methoxyphenyl)benzenemethanol, CAS: 235106-88-4, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₂O₈.

Human XDH(Xanthine dehydrogenase/oxidase) ELISA Kit (96T), CAS: /, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Indicaxanthin, CAS: 2181-75-1, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₆.

Lomifylline, CAS: 10226-54-7, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₄O₃.

N-(4-Amino-3-pyridinyl)-acetamide Hydrochloride, CAS: 676464-96-3, stock: 1.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₃O  •HCl.

N-(4-Amino-3-pyridinyl)-acetamide-d3 Hydrochloride, CAS: /, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆D₃N₃O  •HCl.

N-[4-(1-Allyl-3-butyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylmethyl)phenyl]acetamide, CAS: 628279-02-7, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₅O₃.

N-[4-[1-(2-Fluorobenzyl)-3-butyl-2,6-dixo-2,3,6,7-tetrahydro-1H-purin-8-ylmethyl]phenyl]acetamide, CAS: 628279-07-2, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆FN₅O₃.

PSB 0788, CAS: 1027513-54-7, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇ClN₆O₄S.

PSB 603, CAS: 1092351-10-4, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅ClN₆O₄S.

Rat Xdh(Xanthine dehydrogenase/oxidase) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Theophylline, CAS: 58-55-9, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O₂.

Theophylline-1,3-15N2,13C, CAS: 1246816-25-0, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³CH₈N₂¹⁵N₂O₂.

Theophylline-1,3-15N2-2-13C, CAS: 84718-95-6, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³CH₈N₂¹⁵N₂O₂.

Theophylline-13C2d6, CAS: 1782458-84-7, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₂H₂D₆N₄O₂.

Theophylline-d6, CAS: 117490-39-8, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂D₆N₄O₂.

Xanthine, CAS: 69-89-6, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₄O₂.

Xanthine Amine Congener, CAS: 96865-92-8, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈N₆O₄.

Xanthine Sodium Salt, CAS: 1196-43-6, stock: 7.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃N₄NaO₂.

Xanthine-13C15N2, CAS: 1262670-81-4, stock: 2.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₄N₂¹⁵N₂O₂.

Xanthosine Dihydrate, CAS: 5968-90-1, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₄O₈.

Xanthosine-13C5, CAS: 146-80-5, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₅H₁₂N₄O₆.

Zeaxanthin, 65%, CAS: 144-68-3, stock: 7.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₆O₂.

4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine, CAS: 941685-26-3, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClN₃OSi.

p-Aminomethyl Vorinostat, CAS: 1160823-16-4, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N₃O₃.

Suberoylanilide Hydroxamic Acid, CAS: 149647-78-9, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₃.

Suberoylanilide Hydroxamic Acid β-D-Glucuronide, CAS: 863456-50-2, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈N₂O₉.

Suberoylanilide Hydroxamic Acid β-D-Glucuronide Sodium Salt, CAS: /, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇N₂NaO₉.

Suberoylanilide Hydroxamic Acid-13C6, CAS: /, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₆H₂₀N₂O₃.

Suberoylanilide-d5 Hydroxamic Acid, CAS: 1132749-48-4, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₅N₂O₃.

Suberoylanilide-d5 Hydroxamic Acid β-D-Glucuronide, CAS: /, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅N₂O₉.

Vorapaxar Sulfate, CAS: 705260-08-8, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₅FN₂O₈S.

Vorapaxar-d5 Sulfate, CAS: /, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀D₅FN₂O₈S.

3-Pyridylsulfonic Acid, CAS: 636-73-7, stock: 4.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO₃S.

5-​(2-Fluorophenyl)​-​1H-​pyrrole-​3-​carbonitrile, CAS: 1240948-77-9, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇FN₂.

N-Desmethyl-2-chloro-vonoprazan, CAS: /, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃ClFN₃O₂S.

(3E)-4-(3-Hydroxyphenyl)-3-buten-2-one, CAS: 22214-29-5, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂.

(R)-3’-Hydroxy Warfarin, CAS: 124997-75-7, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

(R)-6-Hydroxy Warfarin, CAS: 63740-75-0, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

(R)-7-Hydroxy Warfarin, CAS: 63740-76-1, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

(S)-3’-Hydroxy Warfarin, CAS: 124952-36-9, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

(S)-6-Hydroxy Warfarin, CAS: 63740-80-7, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

(S)-7-Hydroxy Warfarin, CAS: 63740-81-8, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

(S)-8-Hydroxy Warfarin, CAS: 63740-82-9, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

10-Hydroxy Warfarin(Mixture of Diastereomers), CAS: 83219-99-2, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

10-Hydroxy Warfarin β-D-Glucuronide, CAS: 1007224-61-4, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₁.

10-Hydroxy Warfarin-d5(Mixture of Diastereomers), CAS: 1286117-65-4, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₁D₅O₅.

3-(o-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one, CAS: 15156-56-6, stock: 5.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆O₂.

6-Benzyloxy-4-acetyl Warfarin, CAS: /, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄O₆.

6-Hydroxy Warfarin β-D-Glucuronide D Disodium Salt Hydrate, CAS: /, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂Na₂O₁₁  •xH₂O.

6-Hydroxy Warfarin β-D-Glucuronide D O-Methyl Triacetate, CAS: /, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄O₁₅.

6-Hydroxy-4-acetyl Warfarin, CAS: /, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈O₆.

7-Hydroxy Warfarin β-D-Glucuronide Disodium Salt, CAS: /, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂Na₂O₁₁.

8-Hydroxy Warfarin β-D-Glucuronide, CAS: 1007224-60-3, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₁.

Dehydro Warfarin, CAS: 67588-18-5, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O₄.

Dehydro Warfarin-d5, CAS: 1346606-43-6, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₉D₅O₄.

Ethyl (2’-Hydroxy-3’-benzyloxybenzoyl)acetate, CAS: 1796932-84-7, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₅.

rac-2-Methyl-2,3-epoxy-4-phenyl-4H-pyrano[3,2-c]benzopyran-5-one, CAS: 1217816-92-6, stock: 9.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O₄.

rac-2-Methyl-4-phenyl-4H-pyrano[3,2-c]benzopyran-5-one, CAS: 15151-14-1, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O₃.

(2S,3R,4S,5S,6S)-2-(((2-((2-((2,4-Dimethylphenyl)thio)phenyl)(2-hydroxyethyl)amino)ethyl)amino)oxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate, CAS: /, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₀N₂O₁₁S.

(2S,3R,4S,5S,6S)-2-(((2-((2-Bromoethyl)(2-((2,4-dimethylphenyl)thio)phenyl)amino)ethyl)amino)oxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl Triacetate, CAS: /, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₉BrN₂O₁₀S.

(2S,3S,4R,5R,6S)-6-(((2-((2-((2,4-Dimethylphenyl)thio)phenyl)(2-hydroxyethyl)amino)ethyl)amino)oxy)-5-hydroxy-2-(methoxycarbonyl)tetrahydro-2H-pyran-3,4-diyl Diacetate, CAS: /, stock: 1.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₈N₂O₁₀S.

1-O-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)-β-D-glucopyranuronic Acid 2,3,4-Triacetate Methyl Ester, CAS: 319926-19-7, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₁₂.

1-O-Acetamido-β-D-glucopyranuronic Acid 3,4-Diacetate Methyl Ester, CAS: /, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₁₀.

1-O-Amino-β-D-glucopyranuronic Acid 2,3,4-Triacetate Methyl Ester, CAS: 319926-20-0, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₁₀.

1-[4-[2-[(2,4-Dimethylphenyl)thio]phenyl]-1-piperazinyl]ethanone, CAS: 1801352-86-2, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂OS.

2,2’-[[2-[(2,4-Dimethylphenyl)thio]phenyl]imino]bis-ethanol, CAS: 1818381-14-4, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₂S.

2-[(2,4-Dimethylphenyl)sulfanyl]aniline, CAS: 1019453-85-0, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅NS.

3-Chloro-2,4-dimethyl-benzenesulfonyl Chloride, CAS: 1783755-80-5, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈Cl₂O₂S.

3-Chloro-Vortioxetine Hydrobromide, CAS: /, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂BrClN₂S.

4-[2-[(2,4-Dimethylphenyl)thio]phenyl]-2-morpholinol, CAS: /, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO₂S.

4-[2-[(2,4-Dimethylphenyl)thio]phenyl]-2-morpholinone, CAS: 1818381-15-5, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₂S.

4-[2-[(2,4-Dimethylphenyl)thio]phenyl]-morpholinyl-2-N-1-O-amino-β-D-glucopyranuronic Acid 2,3,4-Triacetate Methyl Ester, CAS: /, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₂O₁₁S.

5-Chloro-2,4-dimethylbenzene-1-thiol, CAS: 1823050-95-8, stock: 6.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉ClS.

5-Chloro-Vortioxetine Hydrobromide, CAS: /, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂BrClN₂S.

N,N-Bis(2-chloroethyl)-2-[(2,4-dimethylphenyl)thio]-benzenamine, CAS: 1979142-78-3, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁Cl₂NS.

N-(2-(Aziridin-1-yl)ethyl)-2-((2,4-dimethylphenyl)thio)aniline, CAS: 1928741-86-9, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂N₂S.

N-Hydroxy Vortioxetine O-β-D-Glucuronide 3,4,5 Triacetate, CAS: /, stock: 3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₂O₁₀S.

N-Hydroxy Vortioxetine O-β-D-Glucuronide Sodium Salt, CAS: /, stock: 4.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₂NaO₇S.

N1-(2-Chloroethyl)-N2-(2-((2,4-dimethylphenyl)thio)phenyl)ethane-1,2-diamine, CAS: 1928741-88-1, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃ClN₂S.

N’-(2,4-Dimethylphenyl) Vortioxetine, CAS: 1446751-00-3, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀N₂S.

N’-(2,4-Dimethylphenyl) Vortioxetine-d8, CAS: /, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂D₈N₂S.

O-t-Butyldiphenylsilylhydroxylamine, CAS: 103587-51-5, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NOSi.

(αR,​βR)​-​rel-6-​Chloro-​α-​(2,​4-​difluorophenyl)​-​5-​fluoro-​β-​methyl-​α-​(1H-​1,​2,​4-​triazol-​1-​ylmethyl)​-4-​pyrimidineethanol, CAS: 137234-76-5, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃ClF₃N₅O.

4-Hydroxyvoriconazole, CAS: 943331-64-4, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₅O₂.

ent-Voriconazole, CAS: 137234-63-0, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₅O.

ent-Voriconazole-d3, CAS: 1314-96-1, stock: 2.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₃F₃N₅O.

Hydroxyvoriconazole, CAS: /, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₅O₂.

rac 5-Desfluoro Voriconazole, CAS: 182369-73-9, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅F₂N₅O.

rac-6-Chloro Voriconazole, CAS: 188416-35-5, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃ClF₃N₅O.

rel-(R,R)-Voriconazole, CAS: 137330-52-0, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₅O.

Voriconazole, CAS: 137234-62-9, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₅O.

Voriconazole N-Oxide, CAS: 618109-05-0, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₅O₂.

Voriconazole-13C3,d3, CAS: 1261395-15-6, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₁D₃F₃N₅O.

Voriconazole-d3, CAS: 1217661-14-7, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₃F₃N₅O.

Voriconazole-d3 N-Oxide, CAS: 1217851-84-7, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₃F₃N₅O₂.

(1R,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylic Acid Ethyl Ester, CAS: 1476028-68-8, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₄.

Voglibose-13C3, CAS: /, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₃H₁₆NO₇.

1-Chloro-2-iodo-4-nitrobenzene, CAS: 74534-15-9, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃ClINO₂.

1-Iodo-3-nitrobenzene, CAS: 645-00-1, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄INO₂.

Vismodegib-d7, CAS: /, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₇D₇Cl₂N₂O₃S.

Virginiamycin, CAS: 11006-76-1, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₉N₇O₁₀ +  C₂₈H₃₅N₃O₇.

Virginiamycin M1 (~90%), CAS: 21411-53-0, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₅N₃O₇.

Virginiamycin M1-d2, CAS: /, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₃D₂N₃O₇.

Virginiamycin S1, CAS: 23152-29-6, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₉N₇O₁₀.

18-O-Allyl Vinorelbine, CAS: /, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₆N₄O₈.

18-O-Allylcatharanthine Vindoline, CAS: /, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₈N₄O₈.

8’-epi Vinorelbine Bitartrate, CAS: /, stock: 3.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₆₆N₄O₂₀.

Deacetyl Vinorelbine Sulfate Salt, CAS: /, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₄N₄O₁₁S.

Deacetyl Vinorelbine-d3 Sulfate Salt, CAS: /, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₉D₃N₄O₇ xH₂SO₄.

Desacetyl Vinorelbine Acid Acetic Acid Salt (~90%), CAS: /, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₀N₄O₇  •  x(C   ₂H₄O₂).

Desacetyl Vinorelbine Bitartrate, CAS: /, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₂N₄O₇•2[C₄H₆O₆].

Vinorelbine N-Methiodide, CAS: 89368-96-7, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₇IN₄O₈.

(+)-(14β)-Dihydrovinpocetine, CAS: 57517-54-1, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₂.

(+)-(14β)-Dihydrovinpocetine-d5, CAS: /, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃D₅N₂O₂.

(+)-cis-Vincaminic Acid Ethyl Ester, CAS: 40163-56-2, stock: 1.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₃.

(+)-cis-Vincaminic Acid Ethyl-d5 Ester, CAS: /, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃D₅N₂O₃.

(-)-(14α)-Dihydrovinpocetine-d5, CAS: /, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃D₅N₂O₂.

(-)-Dihydroapovincaminic Acid Ethyl Ester, CAS: 57327-92-1, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₂.

Apovincaminic Acid Ethyl Ester N-Oxide, CAS: 109741-24-4, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₂O₃.

Apovincaminic Acid Hydrochloride Salt, CAS: 72296-47-0, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃ClN₂O₂.

Apovincaminic Acid-d4, CAS: /, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈D₄N₂O₂.

4-Desacetyl 3-Deoxy Vincristine, CAS: 99435-53-7, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₄N₄O₈.

4-Desacetyl Vincristine Methosulfate, CAS: 06/01/3704, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₈N₄O₁₃S.

4’-Deoxy Vincristine, CAS: 68135-16-0, stock: 6.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₆N₄O₉.

Dolastatin 10 Trifluoroacetate, CAS: /, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₈N₆O₆S  •C₂HF₃O₂.

N-Desformyl-4-desacetyl Vincristine Disulfate Salt, CAS: 1285859-25-7, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₈N₄O₁₆S.

N-Formyl Leurosine (Vincristine Impurity G), CAS: 54022-49-0, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₄N₄O₁₀.

Vincristine N-Oxide, CAS: 947527-73-3, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₆N₄O₁₁.

Vincristine Sulfate, CAS: 2068-78-2, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₈N₄O₁₄S.

Vincristine-d3 Sulfate, CAS: 1217854-24-4, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₅D₃N₄O₁₄S.

Vincristine-d3 Sulfate, CAS: 1246817-10-6, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₅D₃N₄O₁₄S.

Vincristine-d6 xSulfate, CAS: /, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₀D₆N₄O₁₀.

Vincristine-d9 Sulfate, CAS: /, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₄₉D₉N₄O₁₄S.

10-Methoxy Vinpocetine-d5, CAS: /, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃D₅N₂O₃.

cis-Apovincamine, CAS: 4880-92-6, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄N₂O₂.

cis-Apovincamine-d3, CAS: /, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₃N₂O₂.

Ethyl (+)-cis-Epivincaminate, CAS: 77549-92-9, stock: 6.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₃.

Ethyl (13aS,13bS)-13a-Ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]-pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate(Vinpocetine Related Compound C), CAS: /, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈N₂O₃.

Vinpocetine, CAS: 42971-09-5, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₂O₂.

Vinpocetine-d5, CAS: /, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₅N₂O₂.

19’-Oxovincaleukoblastine Sulfate, CAS: /, stock: 6.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₆N₄O₁₀  . x( H₂O₄S).

19’-Oxovincaleukoblastine-d3 Sulfate, CAS: /, stock: 6.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₃D₃N₄O₁₀  . x( H₂O₄S).

3,4-Dimethylbenzoyl Chloride, CAS: 21900-23-2, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉OCl.

3’,4’-Anhydro Vincristine Ditartrate, CAS: /, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₆₆N₄O₂₁.

4-Desacetyl Vinblastine Methosulfate, CAS: 1322625-71-7, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₀N₄O₁₂S.

Anhydro Vinblastine Disulfate Salt, CAS: 81165-17-5, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₀N₄O₁₆S₂.

Anhydro Vinblastine-d3 Disulfate Salt, CAS: /, stock: 4.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₇D₃N₄O₁₆S₂.

Anhydrovinblastine N’b-oxide Sulfate Salt, CAS: 1796934-70-7, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₈N₄O₁₃S.

Catharanthine-d3 Tartrate Salt, CAS: /, stock: 5.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₃N₂O₂ (C₄H₆O₆ ).

Catharanthinic Acid, CAS: 63944-54-7, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₂.

Deacetylvinblastine Hydrazide, CAS: 55383-37-4, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₆N₆O₇.

Desacetyl Desformylvincristine, CAS: 55324-83-9, stock: 3.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₄N₄O₈.

Erysolin, CAS: 504-84-7, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂S₂.

Leurosine Sulfate, CAS: 54081-68-4, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₆N₄O₉•1/2H₂SO₄.

N-Desmethyl Vinblastine, CAS: 18172-50-4, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₆N₄O₉.

O4-Desacetyl Vinblastinic Acid, CAS: 60223-75-8, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₄N₄O₈.

Vinamidine-d3-N-formyl-1-hydroxide Sulfate, CAS: /, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₁D₃N₄O₁₂ . x( H₂O₄S).

Vinamidine-N-formyl-1-hydroxide Sulfate, CAS: /, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₄N₄O₁₂ . x( H₂O₄S).

Vinblastine Sulfate, CAS: 143-67-9, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₈N₄O₉ +xH₂SO₄.

Vinblastine Sulphate-d3, CAS: /, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₅D₃N₄O₉ . xH ₂SO₄.

Vinblastine-d3 Sulfate, CAS: 1246818-72-3, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₇D₃N₄O₁₃S.

Vinblastine-d5-methylchloride Iodide, CAS: /, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₅D₅ClIN₄O₉.

Vinblastine-d6 Sulfate, CAS: /, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₄D₆N₄O₁₃S.

Vinblastine-methylchloride Iodide, CAS: /, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₆₀ClIN₄O₉.

Vindesine Sulfate Salt, CAS: 59917-39-4, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₇N₅O₁₁S.

Vinorelbine Bitartrate, CAS: 125317-39-7, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₆₆N₄O₂₀.

Vinorelbine-d3 Bitartrate, CAS: /, stock: 3.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₆₃D₃N₄O₂₀.

(R)-Viloxazine Hydrochloride, CAS: 56287-63-9, stock: 4.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀ClNO₃.

(R)-Viloxazine-d5 Hydrochloride, CAS: 1246815-04-2, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅D₅ClNO₃.

(S)-Viloxazine Hydrochloride, CAS: 56287-61-7, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀ClNO₃.

(S)-Viloxazine-d5 Hydrochloride, CAS: 1246816-39-6, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅D₅ClNO₃.

2-Hydroxymethylmorpholine-4-carboxylic Acid tert-Butyl Ester, CAS: 135065-69-9, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄.

5-Oxo Viloxazine, CAS: 56305-61-4, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄.

5-Oxo Viloxazine-d5, CAS: 1794979-21-7, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₅NO₄.

N-Methyl Viloxazine, CAS: 48173-47-3, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₃.

N-Methyl Viloxazine-d3, CAS: 1794811-35-0, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈D₃NO₃.

rac N-tert-Butoxycarbonyl Viloxazine, CAS: 1330189-29-1, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇NO₅.

rac Viloxazine Hydrochloride, CAS: 35604-67-2, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀ClNO₃.

rac Viloxazine-d5 Hydrochloride, CAS: 1276483-10-3, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅D₅ClNO₃.

(2R)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile, CAS: 565452-98-4, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉ClN₂O.

(2R)-Vildagliptin, CAS: 1036959-27-9, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₂.

(2S)-1-(2-Chloroacetyl)-2-9-pyrrolidinecarbonitrile, CAS: 207557-35-5, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉ClN₂O.

(2S)-1-(2-Chloroacetyl)-2-9-pyrrolidinecarbonitrile-d1, CAS: /, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈DClN₂O.

(2S)-1-(2-Hydroxy-2-(((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile, CAS: /, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₃.

(2S,2’S)-1,1’-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis-2-pyrrolidinecarbonitrile, CAS: 1036959-23-5, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃N₅O₃.

(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)carbamic Acid 1,1-Dimethylethyl Ester, CAS: 847795-89-5, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₃.

(S)-1-((E)-2-(((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)imino)acetyl)pyrrolidine-2-carbonitrile, CAS: /, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃N₃O₂.

(S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxamide, CAS: 214398-99-9, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁ClN₂O₂.

(S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxamide-D3, CAS: /, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈D₃ClN₂O₂.

(S)-1-(Hydroxyacetyl)-2-pyrrolidinecarboxamide, CAS: 96166-39-1, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₂O₃.

5-Aminotricyclo[3.3.1.13,7]decane-1,3-diol, CAS: 1382839-19-1, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₂.

Hydroxy Vildagliptin, CAS: /, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₃.

N-(3,5-Dihydroxytricyclo[3.3.1.13,7]dec-1-yl)carbamic Acid 1,1-Dimethylethyl Ester, CAS: 1863082-19-2, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₄.

N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-prolinamide, CAS: 565453-39-6, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇N₃O₃.

N-Hydroxy Vildagliptin, CAS: /, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₃.

Vildagliptin, CAS: 274901-16-5, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₂.

Vildagliptin Carboxylic Acid Lithium Salt Hydrate, CAS: /, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅LiN₂O₄•xH₂O.

Vildagliptin Cyclo Imidamide, CAS: /, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₂.

Vildagliptin β-D-Glucuronide, CAS: 1147403-03-9, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃N₃O₈.

Vildagliptin-13C5, CAS: /, stock: 6.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₅H₂₅N₃O₂.

Vildagliptin-13C5,15N, CAS: 1044741-01-6, stock: 4.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₅H₂₅N₂¹⁵NO₂.

Vildagliptin-d3, CAS: 1217546-82-1, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂D₃N₃O₂.

(1R)-1-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-[[(1S)-2-hydroxy-1-phenylethyl]amino]ethanol, CAS: /, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₄.

(1R)-2-[[6-[2-[(2,6-Dichlorobenzyl)oxy]ethoxy]hexyl]amino]-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol, CAS: 503068-37-9, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇Cl₂NO₅.

(R)-1-(2,6-Dichlorophenyl)-21-(4-hydroxy-3-(hydroxymethyl)phenyl)-2,5,12-trioxa-19-azahenicosan-21-ol 2,2,2-Triphenylacetate, CAS: /, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₆₁Cl₂NO₈.

(R)-2-Amino-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol, CAS: 208925-08-0, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₃.

(R)-3-[6-[2-(2,6-Dichlorobenzyloxy)ethoxy]hexyl]-5-(2,2-dimethyl-4H-benzo[1,3]dioxin-6-yl)oxazolidin-2-one, CAS: 503068-36-8, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₅Cl₂NO₆.

2-[(2,6-Dichlorobenzyl)oxy]ethanol-d4, CAS: /, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆D₄Cl₂O₂.

2-[2-(6-Bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene, CAS: 503070-57-3, stock: 8.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁BrCl₂O₂.

2-[2-(6-Bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene-d4, CAS: /, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇D₄BrCl₂O₂.

(-)-1,6-Epoxyisodihydrocarveol, CAS: 35692-59-2, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₂.

(1α,3R,4α,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1,4-dihydroxy-cyclohexanecarboxylic Acid Methyl Ester, CAS: 135711-62-5, stock: 1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₄₂O₆Si₂.

(1α,3R,4α,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-hydroxy-4-(1H-imidazol-1-ylthioxomethoxy)-cyclohexanecarboxylic Acid Methyl Ester, CAS: 139356-32-4, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₄N₂O₆SSi₂.

(1R,1’S)-Octahydro-1-(2’-iodo-1’-methylethyl)-7a-methyl-inden-4-ol, CAS: /, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃IO.

(1R,1’S)-Octahydro-1-(2’-iodo-1’-methylethyl)-7a-methyl-inden-4-one, CAS: 145372-32-3, stock: 5.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁IO.

(1R,3aR,4S,7aR)-Octahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-1H-inden-4-ol, CAS: 55812-82-3, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₄O.

(1R,3S)-5-((Z)-2-((3aR,7aS)-1-((S)-1-(3-Hydroxy-3-methylbutoxy)ethyl)-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl)vinyl)-4-methylcyclohex-4-ene-1,3-diol, CAS: 142927-18-2, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂O₄.

(1R,3S)-5-((Z)-2-((3aR,7aS)-1-((S)-1-(3-Hydroxy-3-methylbutoxy-d6)ethyl)-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl)vinyl)-4-methylcyclohex-4-ene-1,3-diol, CAS: /, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆D₆O₄.

(1R,3S,Z)-5-((E)-2-((1S,3aS,7aS)-1-((S)-2-Hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, CAS: 158946-41-9, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

(1S,3E,5R)-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylene-3-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-cyclohexanol, CAS: 112670-78-7, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₈O₂Si.

(2-((3R,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)-4-methylenecyclohexylidene)ethyl)diphenylphosphine Oxide, CAS: 213250-64-7, stock: 2.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₁O₃PSi₂.

(2-Cyclopropyl-2-oxoethyl)triphenyl-phosphonium Bromide, CAS: 112849-15-7, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂BrOP.

(2-Methylpyridin-3-yl)acetonitrile, CAS: 101166-73-8, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂.

(24S)-MC 976, CAS: 112849-14-6, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O₃.

(2E,4E)-3-Methyl-5-(4-hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-pentadienenitrile, CAS: 178938-94-8, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO.

(2R)-2-hydroxy-3-(hydroxymethyl)-3-methyl-N-(3-oxo-4-phenylbutyl)butanamide, CAS: 1351758-37-6, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₄.

(2R)-2-hydroxy-3-(hydroxymethyl)-3-methyl-N-(3-oxo-4-phenylbutyl)butanamide-d5, CAS: /, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₅NO₄.

(2S)-2,3-Dimethyl-1,3-butanediol, CAS: 73295-12-2, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₂.

(3-Carboxypropyl)triphenylphosphonium Bromide, CAS: 17857-14-6, stock: 6.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂BrO₂P.

(3β)-3-[(tert-Butyldimethylsilyl)oxy]-chola-5,7-dien-24-oic Acid Methyl Ester, CAS: 146177-13-1, stock: 8.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₂O₃Si.

(3β)-3-[(tert-Butyldimethylsilyl)oxy]-chola-5,7-dien-24-ol, CAS: 146177-15-3, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₂O₂Si.

(3β,22E)-3,25-Dihydroxy-cholesta-5,22-dien-24-one 3-Acetate, CAS: 69425-74-7, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₄O₄.

(3β,22E)-3,25-Dihydroxycholesta-5,22-dien-24-one, CAS: 131550-93-1, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O₃.

(3β,22E)-Ergosta-5,7,22-triene-3,24,25-triol, CAS: /, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₃.

(3β,22E)-Ergosta-5,7,22-triene-3,24,25-triol 3-Acetate, CAS: 69425-77-0, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₆O₄.

(3β,22E)-Ergosta-5,7,22-triene-3,24,25-triol-d3, CAS: /, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁D₃O₃.

(3β,22E,24ξ)-Ergosta-5,22-diene-3,24,25-triol 3-Acetate, CAS: 69425-75-8, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₈O₄.

(3β,22E,24ξ)-Ergosta-5,22-diene-3,24,25-triol-d3 3-Acetate, CAS: /, stock: 6.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₅D₃O₄.

(3β,4β)-3,4-Dihydroxy-chol-5,7-diene-24-carboxylic Acid Methyl Ester, CAS: /, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀O₄.

(3β,5E,7E)-3-(tert-Butyldimethylsilyloxy)-9,10-secocholestra-5,7,10(19)-triene-24-carboxylic Acid Methyl Ester, CAS: /, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₄O₃Si.

(3β,5Z,7E,22E)-3-O-tert-Butyldimethylsilyl-25-tetrahydropyranyl-23-phenylsulfonyl-9,10-secoergosta-5,7,10(19)-triene-3,22,25-triol;, CAS: /, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₇₂O₆SSi.

(3β,5Z,7E,24R)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-24-hydroxy-9,10-secochola-5,7,10(19)-triene-24-carboxylic Acid Methyl Ester, CAS: 252893-56-4, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₄O₄Si.

(3β,5Z,7R,8α,22E)-3S-tert-Butyldimethylsilyl-9,10-secoergosta-5,10(19),22-triene-7,8-diol, CAS: 131852-63-6, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₀O₃Si.

(3β,5Z,7R,8α,22E)-9,10-Secoergosta-5,10(19),22-triene-3,7,8-triol, CAS: 84985-78-4, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O₃.

(3β,6S,7E)-6,19-Sulfonyl-9,10-secocholesta-5(10),7-dien-3-ol, CAS: 71726-02-8, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃S.

(3R)-β-Cryptoxanthin, CAS: 472-70-8, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₆O.

(3R-trans)-[2-[3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexylidene]ethyl]diphenyl-phosphine Oxide, CAS: 139356-39-1, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₁O₃PSi₂.

(3R-trans)-[3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexylidene]-acetic Acid Ethyl Ester, CAS: 139356-36-8, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₄O₄Si₂.

(3S)-1,3-Bis-O-(tert-Butyldimethylsilyl)-3-hydroxy-5,6-trans-vitamin D2, CAS: 111594-58-2, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₂O₂Si₂.

(3S)-1,3-Bis-O-tert-Butyldimethylsilyl 3-Hydroxy Vitamin D2 SO2 Adduct (Mixture of Diastereomers), CAS: 170081-46-6, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₂O₄SSi₂.

(3S)-tert-Butyldimethylsilyl Vitamin D2 SO2 Adduct (Mixture of Diastereomers), CAS: 251445-16-6, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₈O₃SSi.

(3S,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexanol, CAS: /, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₄₀O₃Si₂.

(3S,5S)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-hydroxy-cyclohexanecarboxylic Acid Methyl Ester, CAS: 139356-33-5, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₄₂O₅Si₂.

(3S,5S)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-hydroxy-cyclohexanemethanol, CAS: 139356-34-6, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₄₂O₄Si₂.

(4-Chloro-3,5-dimethylpyridin-2-yl)methanol Hydrochloride, CAS: 143016-70-0, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁Cl₂NO.

(5E)-1,3-Bis-O-(tert-Butyldimethylsilyl)-24-oxo-calcipotriene, CAS: 112849-17-9, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₆O₃Si₂.

(5E)-1,3-Bis-O-(tert-Butyldimethylsilyl)-24-oxo-calcipotriene-d4, CAS: /, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₂D₄O₃Si₂.

(5E,24R)-1,3-Bis-O-(tert-Butyldimethylsilyl)-calcipotriene, CAS: 112849-26-0, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₈O₃Si₂.

(5E,24R)-Calcipotriene, CAS: 112849-47-5, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₃.

(2S)-2-[(Ethylthio)carbonyl]-5-oxo-1-pyrrolidinecarboxylic Acid tert-Butyl Ester, CAS: 1298023-90-1, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₄S.

(5Z,7E)-(1S,3R)-1,3-Bis[tert-butyl(dimethylsilyl)oxy]-22-hydroxy-23,24-dinor-9,10-secochola-5,7,10(19)-triene, CAS: 114694-12-1, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₂O₃Si₂.

(2S)-5-Oxo-2-pyrrolidinecarbothioic Acid S-Ethyl Ester, CAS: 1298024-11-9, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₂S.

(E)-2-(2-Aminoethyl)but-2-enoic Acid Hydrochloride, CAS: 1379403-11-8, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C6H12ClNO2.

(R)-Vigabatrin, CAS: 77162-51-7, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂.

(S)-Vigabatrin, CAS: 74046-07-4, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂.

(S)​-4-​[(Methoxycarbonyl)​amino]​-5-​hexenoic Acid Ethyl Ester, CAS: 148073-34-1, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₄.

2-(2-Aminobut-3-enyl)malonic Acid, CAS: 1378466-25-1, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₄.

2-Ethenyl-5-oxo-1-pyrrolidinecarboxylic Acid tert-Butyl Ester, CAS: 160428-64-8, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₃.

2-Oxo-5-vinylpyrrolidine-3-carboxamide, CAS: 71107-19-2, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₂.

4-(4-Amino-hex-5-enoylamino)-hex-5-enoic Acid, CAS: 794466-81-2, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₃.

4-​Amino-5-​hexenoic Acid Ethyl Ester, CAS: 213758-47-5, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₂.

4-Oxo-6-(2-oxo-5-vinylpyrrolidin-1-yl)hexanoic Acid, CAS: /, stock: 8.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₄.

(E,E,E)-[(12-Bromo-3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy]methyl]benzene, CAS: 71135-56-3, stock: 1.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁BrO.

5-Ethenyl-2-pyrrolidinone, CAS: 7529-16-0, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO.

5-Ethoxy-2-pyrrolidone, CAS: 39662-63-0, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂.

6-Benzenesulfonyl-2-pyrrolidone, CAS: /, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₃S.

(βS,1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-β,7a-dimethyl-1H-indene-1-ethanol, CAS: 128387-35-9, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₂O₃Si₂.

(βS,1R,3aS,4E,7aR)-4-[[(6S)-6-[[(tert-Butyldimethylsilyloxy]-1,3,4,5,6,7-hexahydro-2,2-dioxidobenzo[c]thien-1-yl]methylene]octahydro-β,7a-dimethyl-1H-Indene-1-ethanol, CAS: 344798-31-8, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O₄SSi.

Ethyl 4-Oxo-6-(2-oxo-5-vinylpyrrolidin-1-yl)hexanoate, CAS: /, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₄.

N-Methoxycarbonyl Vigabatrin Ethyl Ester, CAS: 1346600-22-3, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₄.

N-Methoxycarbonyl Vigabatrin-13C,d2 Ethyl Ester, CAS: 1346599-63-0, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³CH₁₅D₂NO₄.

(R)-Mevalonolactone, CAS: 19115-49-2, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₃.

rac-Vigabatrin Hydrochloride, CAS: 1391054-02-6, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂ClNO₂.

rac-Vigabatrin-13C,d2  (Major), CAS: 1330171-61-3, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₉D₂NO₂.

(R)-Trolox, CAS: 53101-49-8, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₄.

(R)​-​(+​)​-​1,​2,​4-​Butanetriol, CAS: 70005-88-8, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀O₃.

(S)-2-(4-((S)-4-(4-(((2-Amino-4-oxo-4,8-dihydropteridin-6-yl)methyl)amino)benzamido)-4-carboxybutanamido)benzamido)pentanedioic Acid, CAS: /, stock: 7.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁N₉O₁₀.

(S)-Trolox, CAS: 53174-06-4, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₄.

1,4-Dihydro-1-(5-methoxy-1H-benzimidazol-2-yl)-2,3,5-trimethyl-4-oxopyridine, CAS: /, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₂.

1-((Dimethylamino)(dimethyliminio)methoxy)-2,5-dioxopyrrolidine-3-sulfonate Sodium Salt Hexafluorophosphate, CAS: /, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N₃NaO₆S⁺ • PF₆⁻.

1-Acetylcyclopropanecarboxylic Acid Methyl Ester, CAS: 38806-09-6, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O₃.

1-Benzyl-3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridin-1-ium Bromide, CAS: /, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈NO₃⁺  • Br ⁻.

1-Benzyl-3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridin-1-ium-d3 Bromide, CAS: /, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅D₃NO₃⁺  • Br ⁻.

1-Bromo-2-cyclohexylethane, CAS: 1647-26-3, stock: 8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅Br.

1-Cyclopropyl-2-(triphenylphosphoranylidene)-ethanone, CAS: 7691-76-1, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁OP.

1-Deoxy-4-O-β-D-glucopyranosyl-1-[4-[(2s)-2-(pentane-1,5-dioic acid)amino]phenylimino]-D-glucitol, CAS: /, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄N₂O₁₄.

13-cis-β-Carotene-d5, CAS: /, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₇D₅.

1α,24-Dihydroxy Vitamin D2, CAS: 124043-51-2, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₃.

1α,24-Dihydroxy Vitamin D2-d3, CAS: /, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁D₃O₃.

1α,25-Dihydroxy Vitamin D2 25-β-D-Glucuronide, CAS: /, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₂O₉.

1α,26-Dihydroxy Vitamin D2, CAS: /, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₃.

1α,26-Dihydroxy Vitamin D3, CAS: 300692-92-6, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

1α-Hydroxy Previtamin D2 +1α-Hydroxy Vitamin D2(Mixture of 2 compounds), CAS: /, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₂.

1α-Hydroxy Vitamin D2, CAS: 54573-75-0, stock: 6.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₂.

1α-Hydroxy Vitamin D2-d3, CAS: /, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁D₃O₂.

1β-Hydroxy Vitamin D2, CAS: 127516-23-8, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₂.

1β-Hydroxy Vitamin D3, CAS: 63181-13-5, stock: 1.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

1β-Hydroxy-5,6-trans-vitamin D2, CAS: 146727-87-9, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₂.

2,2,8-Trimethyl-4H-1,3-dioxino[4,5-c]pyridine-5-carboxylic Acid Hydrochloride, CAS: 82896-36-4, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄.

2,5-Dimethyltetrahydrofolic Acid, CAS: /, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₇O₆.

2-(1,3,3-Trimethylbutyl)-5,7,7-trimethyloctanol, CAS: 36400-98-3, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₈O.

2-(Chloromethyl)-6-methoxy-4-methylpyridine, CAS: 100636-47-3, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀ClNO.

2-(Chloromethyl)-6-methoxy-4-methylpyridine-D3, CAS: /, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₃ClNO.

2-Amino-7-ethyl-4(3H)-pteridinone, CAS: 25716-33-0, stock: 8.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₅O.

Vernakalant Hydrochloride, CAS: 748810-28-8, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂ClNO₄.

Verteporfin, CAS: 129497-78-5, stock: 4.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₂N₄O₈.

Vernakalant-d6 Hydrochloride, CAS: 866455-16-5, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆D₆ClNO₄.

2-Picoline-3-ethanol, CAS: 05/05/1977, stock: 5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO.

2-Quinoxalinone, CAS: 1196-57-2, stock: 1.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O.

2-[(2-Methoxyethyl)thio]-3-methyl-1,4-napthalenedione, CAS: 255906-59-3, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₃S.

20-Hydroxyvitamin D3, CAS: 651734-12-2, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

24,25-Dihydroxy Vitamin D2 3-Hemisuccinate, CAS: /, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₈O₆.

24,25-Dihydroxy Vitamin D3 3-Hemisuccinate, CAS: 76763-28-5, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₈O₆.

24,25-Dihydroxyprevitamin D2, CAS: /, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₃.

24-Methylene Vitamin D2, CAS: /, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂O.

25-Hydroxy Vitamin D2, CAS: 21343-40-8, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₂.

25-Hydroxy Vitamin D2-d6, CAS: 1262843-46-8, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈D₆O₂.

25-Hydroxy Vitamin D3 3-Sulfate Sodium Salt (90%), CAS: /, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₃NaO₅S.

25-Hydroxy Vitamin D3-d6 3-Sulfate Sodium Salt (80%), CAS: /, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₆NaO₅S.

25-Hydroxyvitamin D2 3-Hemisuccinate, CAS: 1612177-56-6, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₈O₅.

25-Hydroxyvitamin D2 3-Hemisuccinate-13C4, CAS: /, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈¹³C₄H₄₈O₅.

3,24-O-Dicyanoethyl 24,25-Dihydroxyvitamin D3, CAS: /, stock: 1.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₀N₂O₃.

3,4-Dihydro-4-oxo-2-[(2,2,2-trifluoroacetyl)amino]-6-pteridinecarboxylic Acid Anhydride 2,2,2-Trifluoroacetic Acid, CAS: 39707-64-7, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₃F₆N₅O₅.

3,4-Dimethylaniline, CAS: 95-64-7, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N.

3-((Benzyloxy)methyl)-7,8,10-trimethylbenzo[g]pteridine-2,4(3H,10H)-dione, CAS: /, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀N₄O₃.

3-(N-Maleimido)propionate Pyridoxamine, CAS: /, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₃O₅.

3-(N-Maleimido)propionate Pyridoxamine-d4, CAS: /, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃D₄N₃O₅.

3-(Phenylsulfonyl)propanoic Acid, CAS: 10154-71-9, stock: 1.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₄S.

3-Aminopropyl-24,25-dihydroxy Vitamin D2, CAS: /, stock: 2.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₁NO₃.

3-Aminopropyl-24,25-dihydroxy Vitamin D3, CAS: /, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₁NO₃.

3-Dehydroxy-3-ene-25-ol Vitamin D3, CAS: 106361-90-4, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O.

3-Dehydroxy-3-ene-25-ol Vitamin D3-d6, CAS: /, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆D₆O.

3-epi-24R 25-Dihydroxy Vitamin D3, CAS: 272776-87-1, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

3-epi-24R 25-Dihydroxy Vitamin D3-d6, CAS: /, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈D₆O₃.

3-epi-25-Hydroxy Vitamin D2, CAS: 908126-48-7, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₂.

3-epi-25-Hydroxy Vitamin D2-d6, CAS: /, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈D₆O₂.

3-Methyl-1,3,5-pentanetriol (Technical Grade), CAS: 7564-64-9, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₃.

3-Methyl-3-[(tetrahydro-2H-pyran-2-yl)oxy]-2-butanone, CAS: 60283-66-1, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₃.

3-O-(2-Cyanoethyl)-24,25-dihydroxy Vitamin D3, CAS: /, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₇NO₃.

3-O-(tert-Butyldimethylsilyl)-5,6-trans-vitamin D2, CAS: 104846-63-1, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₈OSi.

3-O-Dinitrobenzoyl-25-hydroxy Vitamin D2, CAS: /, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₆N₂O₇.

3-Pentanone, CAS: 96-22-0, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O.

3-Pentanone-d6, CAS: 53389-25-6, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₆O.

3-Propylnitrile-24,25-Dihydroxy Vitamin D2, CAS: /, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₇NO₃.

3-[[(1S,3Z)-4-Methylene-3-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,3E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]cyclohexyl]oxy]propanenitrile, CAS: 932023-10-4, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₇NO₂.

3β,4β-Diacetyloxy-chol-5-ene-24-carboxylic Acid Ethyl Ester, CAS: /, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₆O₇.

4,5,6,7-Tetrahydro  2-Acetamido Folic Acid Bismethyl Ester-d4, CAS: /, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅D₄N₇O₇.

4-(1-Ethoxyethoxy)-2-methyl-1,2-butanediol, CAS: /, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀O₄.

4-(1-Ethoxyethoxy)-2-methyl-1,2-butanediol 1-(4-Methylbenzenesulfonate), CAS: /, stock: 2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₆S.

4-(1-Ethoxyethoxy)-2-methyl-1-butene, CAS: 261378-88-5, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₂.

4-(4-(Chloro(pyridin-2-yl)methyl)phenoxy)piperidine, CAS: /, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂O.

4-Chloro-3,5-dimethylpicolinic Acid, CAS: 447461-22-5, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₂.

4-Chloro-3,5-dimethylpicolinonitrile, CAS: 1323392-95-5, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇ClN₂.

4-Chloro-3,5-dimethylpyridine-2,6-dicarboxylic Acid, CAS: /, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈ClNO₄.

4-Deoxy Pyridoxine Hydrochloride, CAS: 148-51-6, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂ClNO₂.

4-Hydroxy-3,5-dimethylpicolinic Acid, CAS: 447461-21-4, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

(3,​4-​Dimethoxyphenyl)​acetic Acid(Homoveratric Acid), CAS: 93-40-3, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₄.

4-[2-(3,4-Dihydro-6,7-dimethoxy-4-methyl-3-oxo-2-quinoxalinyl)ethyl]-1,2,4-triazolindine-3,5-dione, CAS: 132788-54-6, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₅O₅.

4α,25-Dihydroxy Vitamin D3, CAS: 1374022-57-7, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

5-Hydroxyveratric Acid, CAS: 01/08/1916, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₅.

4β,25-Dihydroxy Vitamin D3, CAS: 573951-39-0, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

5,6-Dihydro-4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2H-pyran-2-ol-d6, CAS: /, stock: 1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₆O₂.

5,6-trans-Vitamin D2, CAS: 51744-66-2, stock: 4.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O.

5-(1-Ethoxyethoxy)-3-hydroxy-3-methylpentanenitrile, CAS: /, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₃.

5-(Chloromethyl)-2-fluoropyridine, CAS: 315180-15-5, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClFN.

5-Chloro-6-(((3,4-dimethoxyphenyl)amino)methyl)quinazoline-2,4-diamine, CAS: /, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClN₅O₂.

5-Chloro-6-((o-tolyamino)methyl)quinazoline-2,4-diamine, CAS: /, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆ClN₅.

5-Hydroxy-6-methyl-4-[[(4-methylphenyl)imino]methyl]-3-pyridinemethanol-d3, CAS: /, stock: 2.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃D₃N₂O₂.

5’-Deoxy-5’-(methylthio)adenosine, CAS: 2457-80-9, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₅O₃S.

5’-Deoxy-5’-(methylthio)adenosine-d3, CAS: /, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂D₃N₅O₃S.

6-Hydroxy-N,N,N-trimethylhexan-1-aminium Bromide, CAS: 118843-18-8, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₂BrNO.

6-tert-Butyldimethylsilyloxy-4-(1-methylethenyl)-1-methyl-cyclohexane 1,2-Epoxide, CAS: 121289-19-8, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₀O₂Si.

7,8-Dehydro Pregnenolone, CAS: 1158830-87-5, stock: 5.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₂.

8-Epihydroxocobalamin, CAS: /, stock: 4.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₈₉CoN₁₃O₁₅P.

8-[6-Methyl-furo[3,40c]pyridin-7-yloxy]theophylline, CAS: 1797911-12-6, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₅O₄.

Acetyl Vitamin B12, CAS: 855207-36-2, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₉₀CoN₁₄O₁₅P.

anti- vitamin D binding protein antibody, CAS: /, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

anti- Vitamin D binding protein antibody, CAS: /, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

beta-Doxercalciferol, CAS: /, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O₂.

Betamethasone-17-butyrate-21-propionate, CAS: 01/02/5534, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₉FO₇.

BGP 15, CAS: 66611-37-8, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₄O₂ • 2(HC l).

Bovine 25-OHD2(Vitamin D2) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine FA/VB9(Folic Acid/Vitamin B9) ELISA Kit (96T), CAS: /, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine VD3(Vitamin D3) ELISA Kit (96T), CAS: /, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Butyl 1-((1R,4R,E)-4-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-hydroxypent-2-en-1-yl)cyclopropanecarboxylate, CAS: /, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₆O₅Si₂.

Butyl 1-((1S,4R,E)-4-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-hydroxypent-2-en-1-yl)cyclopropanecarboxylate, CAS: /, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₆O₅Si₂.

Butyl 1-((R,E)-4-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-Bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)pent-2-enoyl)cyclopropanecarboxylate, CAS: /, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₄O₅Si₂.

Calcioic Acid, CAS: 76794-34-8, stock: 9.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₃.

Calcipotriene-d4, CAS: /, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅D₄O₃.

Co-​(cyano-​κC)​-​Cobinamide dihydrogen phosphate (ester) inner salt 3’-​ester with (1,​3-​dihydro-​5,​6-​dimethyl-​1-​α-​D-​ribofuranosyl-​2H-​benzimidazol-​2-​one-​κN3), CAS: 119157-02-7, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₈₈CoN₁₄O₁₅P.

(3,​4-​Dimethoxyphenyl)​acetonitrile(Homoveratronitrile), CAS: 93-17-4, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

Vilazodone Ethyl Ester, CAS: 163521-11-7, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₄O₃.

CPH Hydrochloride, CAS: 164364-89-0, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₃ •  HCl.

(R)-(+)-Nor Verapamil Hydrochloride, CAS: 147158-71-2, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇ClN₂O₄.

(R)-(+)-Verapamil Hydrochloride, CAS: 38176-02-2, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈N₂O₄ • (HCl).

(R)-(+)-Verapamil-d6, CAS: 1796641-49-0, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂D₆N₂O₄.

(R)-(+)-Verapamil-d6 (2S,​3S)​-2,​3-​Bis(phenylmethoxy)​-butanedioic Acid, CAS: /, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂D₆N₂O₄ • ( C₁₂H₁₀O₉).

(R)-(+)-Verapamil-d6 Hydrochloride, CAS: 1795786-09-2, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃D₆ClN₂O₄.

1-(1-(4-(Benzyloxy)phenyl)-2-(dimethylamino)ethyl)cyclohexanol, CAS: 93413-61-7, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₂.

D-(+)-Malic Acid, CAS: 636-61-3, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₅.

(S)-(-)-Nor Verapamil Hydrochloride, CAS: 147158-72-3, stock: 9.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇ClN₂O₄.

(S)-(-)-Verapamil Hydrochloride, CAS: 36622-28-3, stock: 7.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉ClN₂O₄.

(S)-(-)-Verapamil-d3 Hydrochloride, CAS: 1398112-33-8, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆D₃ClN₂O₄.

1-(Cyano-(4-methoxyphenyl)ethyl)cyclohexanol-d11, CAS: /, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₁₁NO₂.

1-(Cyano-(4-methoxyphenyl)methyl)cyclohexanol, CAS: 93413-76-4, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₂.

(S)-Verapamilamide, CAS: 204642-98-8, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆N₂O₅.

1-[(4-Benzyloxyphenyl)-(dimethylcarbamoyl)methyl]cyclohexanol, CAS: 955365-79-4, stock: 3.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉NO₃.

1-[2-Amino-1-(4-methoxyphenyl)ethyl]cyclohexanol Hydrochloride, CAS: 130198-05-9, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₂ •HCl.

D-Xylo-2-Hexulosonic Acid, CAS: 21675-47-8, stock: 8.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₇.

3,4-Dimethoxy-α-(1-methylethyl)benzeneacetonitrile, CAS: 20850-49-1, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₂.

D-Xylo-2-Hexulosonic Acid Butyl Ester, CAS: /, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₇.

3,4-Dimethoxy-α-(1-methylethyl-d7)benzeneacetonitrile, CAS: /, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀D₇NO₂.

3,4-Dimethoxy-α-[3-(methylamino)propyl]-α-(1-methylethyl)-benzeneacetonitrile Hydrochloride, CAS: 67775-97-7, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇ClN₂O₂.

2-(4-(Benzyloxy)phenyl)-N,N-dimethylacetamide, CAS: 919475-15-3, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₂.

4-Benzyloxyphenylacetonitrile, CAS: 838-96-0, stock: 9.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO.

4-Hydroxy-α-(1-hydroxycyclohexyl)benzeneacetonitrile, CAS: 918344-20-4, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₂.

4-Hydroxy-α-(1-hydroxycyclohexyl)benzeneacetonitrile 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃NO₁₁.

5-(4-Methoxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5]undecane Hydrochloride, CAS: 93413-56-0, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅NO₂ • (HCl).

D,L-N,N-Didesmethyl Venlafaxine, CAS: 93413-77-5, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₂.

D,L-N,N-Didesmethyl Venlafaxine-d11, CAS: /, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₁₁NO₂.

Diethyl 5-Hydroxy-6-methylpyridine-3,4-dicarboxylate, CAS: 2397-71-9, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₅.

5-Chloro-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile, CAS: 27487-83-8, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂ClNO₂.

Anipamil Hydrochloride, CAS: 94313-88-9, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₃ClN₂O₂.

D,L-N,N-Didesmethyl-N-(4-methoxyphenethyl) Venlafaxine, CAS: 1329795-88-1, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃NO₃.

Anipamil-d25 Hydrochloride, CAS: 1346602-69-4, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₈D₂₅ClN₂O₂.

D 517 Hydrochloride (Verapamil Impurity), CAS: 1794-55-4, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇ClN₂O₄.

D 517-d7 Hydrochloride (Verapamil Impurity), CAS: 1330173-18-6, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀D₇ClN₂O₄.

D,L-O-Desmethyl Venlafaxine N-Oxide, CAS: 1021933-95-8, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₃.

Dihydro-Doxercalciferol, CAS: /, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O₂.

Dihydroxyacetone Phosphate Lithium Salt (>90%), CAS: /, stock: 6.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇O₆P • xLi.

Dihydroxyacetone Phosphate 13C3, CAS: 217961-77-8, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₇O₆P.

N-(2-Chloroethyl)-3,4-dimethoxy-N-methyl-benzeneethanamine Hydrochloride, CAS: 190850-48-7, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁Cl₂NO₂.

N-(3-Chloropropyl)-3,4-dimethoxy-N-methylbenzeneethanamine, CAS: 36770-74-8, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂ClNO₂.

Nor Verapamil Hydrochloride, CAS: 67812-42-4, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇ClN₂O₄.

DL-Malic Acid, CAS: 6915-15-7, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₅.

Nor Verapamil N-β-D-Glucuronide, CAS: 126883-99-6, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₄N₂O₁₀.

Nor Verapamil-d6 Hydrochloride, CAS: 1329651-21-9, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁D₆ClN₂O₄.

DL-Malic Acid-13C4, CAS: 1258274-51-9, stock: 2.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₆O₅.

DL-Malic Acid-2,3,3-d3, CAS: 104596-63-6, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃D₃O₅.

Nor Verapamil-d6 N-β-D-Glucuronide, CAS: /, stock: 4.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₈D₆N₂O₁₀.

Nor Verapamil-d7, Hydrochloride, CAS: 1216413-74-9, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀D₇ClN₂O₄.

Decyclohexanol-ethoxycarbonyl-O-desmethyl Venlafaxine, CAS: 1346600-77-8, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₃.

Decyclohexanol-ethoxycarbonyl-O-desmethyl Venlafaxine-d6, CAS: 1346605-17-1, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃D₆NO₃.

p-O-Desmethyl p-O-Benzyl Verapamil, CAS: 114829-62-8, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₂N₂O₄.

p-O-Desmethyl Verapamil, CAS: 77326-93-3, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆N₂O₄.

Deoxy Venlafaxine, CAS: 1076199-92-2, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NO.

R-Nor-Verapamil-D6, CAS: /, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀D₆N₂O₄ • HCl.

rac D 617 (Verapamil Metabolite), CAS: 34245-14-2, stock: 3.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆N₂O₂.

S-(s)-Verapamil-D6, CAS: 1329611-24-6, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃D₆ClN₂O₄.

S-Nor-Verapamil-D6, CAS: /, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀D₆N₂O₄ • HCl.

Ethyl 4-Methoxyatropate, CAS: 39729-00-5, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₃.

Ethyl α-(p-Methoxyphenyl)-β-(dimethylamino)propionate, CAS: 323176-93-8, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₃.

β-1-Cyclohexen-1-yl-4-methoxy-N,N-dimethyl-benzeneethanamine Hydrochloride, CAS: 93413-79-7, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅NO•HCl.

N-Boc N,O-Didesmethylvenlafaxine, CAS: 1076199-24-0, stock: 1.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₁NO₄.

Ethyl 4-(4-(Chloro(pyridin-2-yl)methyl)phenoxy)piperidine-1-carboxylate, CAS: /, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃ClN₂O₃.

Verapamil-d6, CAS: /, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂D₆N₂O₄.

N-Formyl-1-(2-amino-1-(4-methoxyphenyl)ethyl)cyclohexanol, CAS: 272788-07-5, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₃.

R-Venlafaxine Di-p-toluoyl-D-tartrate Salt, CAS: 272788-00-8, stock: 6.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₅NO₁₀.

Folic Acid 13C1, CAS: /, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³CH₁₇N₇O₆.

rac N,N-Didesmethyl-O-desmethyl Venlafaxine Glucuronide, CAS: 1799830-07-1, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉NO₈.

rac N-Boc-N,O-Didesmethyl Venlafaxine 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₇NO₁₃.

Grundmann’s Ketone, CAS: 66251-18-1, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O.

rac N-Desmethyl-N-(4-methoxyphenethyl) Venlafaxine, CAS: 1346601-14-6, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅NO₃.

rac N-Desmethyl-N-(4-methoxyphenethyl) Venlafaxine-d3, CAS: 1346602-72-9, stock: 9.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂D₃NO₃.

Human CYP27B1 (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CYP27B1(25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human DBP/Vitamin D Binding Protein(Vitamin D Binding Protein) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PROC(Vitamin K-dependent protein C) ELISA Kit (96T), CAS: /, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

S-Venlafaxine-di-p-toluoyl-L-tartrate Salt (2:1), CAS: 93471-25-1, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₇₂N₂O₁₂.

Human PROS1(Vitamin K-dependent protein S) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PROZ(Vitamin K-dependent protein Z) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human VDR(Vitamin D3 receptor) ELISA Kit (96T), CAS: /, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human vitamin D binding protein ELISA Kit (96T), CAS: /, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Venlafaxine N-Oxide, CAS: 1094598-37-4, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NO₃.

Venlafaxine-d6 N-Oxide, CAS: /, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁D₆NO₃.

Human VKORC1(Vitamin K epoxide reductase complex subunit 1) ELISA Kit (96T), CAS: /, stock: 4.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Inhoffen Lythgoe Diol, CAS: 64190-52-9, stock: 1.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄O₂.

Isopyridoxal Hydrochloride, CAS: 90005-85-9, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃ •  HCl.

Isotachysterol, CAS: 469-06-7, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O.

Isovitamin D3 (90%), CAS: 42607-12-5, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O.

α-Ionylideneacetonitrile, CAS: 58260-81-4, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N.

trans-Violaxanthin Diacetate, CAS: /, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₆₀O₆.

Violaxanthin (Mixture of Diastereomers), CAS: /, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₆O₄.

δ-Tocotrienol, CAS: 25612-59-3, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₂.

δ-Tocotrienol-d6, CAS: /, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄D₆O₂.

L-(-)-Malic Acid, CAS: 97-67-6, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₅.

L-(-)-Malic Acid-13C4, CAS: 150992-96-4, stock: 4.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₆O₅.

L-Methionine-S-methyl Sulfonium Chloride, CAS: 1115-84-0, stock: 7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₂S.

L-Methionine-S-methyl Sulfonium Chloride-d6 Hydrochloride, CAS: /, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₆Cl₂NO₂S.

L-Proline, CAS: 147-85-3, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₂.

L-Proline tert-Butyl Ester, CAS: 2812-46-6, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₂.

L-Proline-13C5,15N, CAS: /, stock: 2.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₉¹⁵NO₂.

L-Proline-2,5,5-d3, CAS: 65807-22-9, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆D₃NO₂.

L-Proline-N-Fmoc, CAS: 71989-31-6, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₄.

Lexacalcitol, CAS: 131875-08-6, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₄.

Lumiflavin N3-Ethyl Alcohol, CAS: /, stock: 4.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₄O₃.

Lumiflavin N3-Ethyl Bromide, CAS: /, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅BrN₄O₂.

Lumisterol, CAS: 474-69-1, stock: 2.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O.

Lumisterol-d3, CAS: /, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁D₃O.

Lumisterol-d5, CAS: /, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉D₅O.

2,3,4,5-Tetrahydro-1,5-methano-1H-3-benzazepine-7,8-diamine, CAS: 808120-35-6, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃.

2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine, CAS: 230615-69-7, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄F₃N₃O.

(3S)-3-Methylpyrrolidine, CAS: 69498-25-5, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁N.

(D-Asn)-Desmopressin, CAS: /, stock: 1.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₄N₁₄O₁₂S₂ • x( C₂H₄O₂).

4-Nitrobenzoyl Varenicline, CAS: 1329651-19-5, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆N₄O₄.

7,8,9,10-Tetrahydro-6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine 1,4-Dioxide-d4, CAS: /, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₄N₃O₂.

7,8,9,10-Tetrahydro-8-(trifluoroacetyl)-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine, CAS: 230615-70-0, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂F₃N₃O.

7,8,9,10-Tetrahydro-8-methyl-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine, CAS: 328055-92-1, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃.

1,2,3,4-Tetrahydro-1-[(4-methylphenyl)sulfonyl]-5H-1-benzazepin-5-one, CAS: 24310-36-9, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₃S.

1,2,4,5-Tetrahydro-3H-1,4-benzodiazepin-3-one, CAS: 168080-43-1, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O.

Hydroxy Varenicline, CAS: 357424-21-6, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O.

(2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone, CAS: 1001264-89-6, stock: 7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂ClN₅O₂.

1,3,4,5-Tetrahydro-2H-1,5-benzodiazepin-2-one, CAS: 07/07/5755, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O.

1-(Benzyloxycarbonylamino)cyclopropyl-1-carboxylic Acid, CAS: 84677-06-5, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₄.

Hydroxy Varenicline N-Trifluoroacetic Acid Salt, CAS: 357426-10-9, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂F₃N₃O₂.

Combimetinib-d9, CAS: /, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₂D₉F₃IN₃O₂.

N-Formyl Varenicline, CAS: 796865-82-2, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₃O.

Vemurafenib, CAS: 918504-65-1, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈ClF₂N₃O₃S.

Vemurafenib-d5, CAS: 1365986-90-8, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₃D₅ClF₂N₃O₃S.

1-Methyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine, CAS: 32900-36-0, stock: 10g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

2-Amino-n-cyclopropyl-acetamide, CAS: 120436-02-4, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O.

p-Nitrophenyl Carbonate 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: 228412-71-3, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₁₄.

Varenicline Carbamoyl 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉N₃O₁₁.

Mouse Cyp27b1 (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 2.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Varenicline Carbamoyl β-D-Glucuronide, CAS: 535920-98-0, stock: 6.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁N₃O₈.

Varenicline Carbamoyl β-D-Glucuronide Methyl Ester, CAS: /, stock: 1.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₃O₈.

Mouse DBP/GC(Vitamin D-binding protein) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Pros1(Vitamin K-dependent protein S) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3-Iodo-Tyr-Desmopressin Trifluoroacetic Acid Salt, CAS: /, stock: 5.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₃IN₁₄O₁₂S₂ • x( C₂HF₃O₂).

Varenicline Lactam, CAS: 873302-30-8, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N₃O.

Mouse Protein Z(Vitamin K-dependent protein Z) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Vdr(Vitamin D3 receptor) ELISA Kit (96T), CAS: /, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Varenicline N-Glucoside, CAS: 873302-31-9, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃N₃O₅.

N,N,N-Trimethyl-3-[[[1-[4-(3,5-dihydro-3,5-dioxo-4H-1,2,4-triazol-4-yl)phenyl]ethylidene]amino]oxy 1-Propanaminium Bromide, CAS: 1318790-34-9, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂BrN₅O₃.

N-Amino-D-proline, CAS: 10139-05-6, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O₂.

N-Boc-2-methyl-L-proline, CAS: 103336-06-7, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄.

8-(L-Arg)Desmopressin Trifluoroacetic Acid Salt, CAS: /, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₄N₁₄O₁₂S₂  • (C ₂HF₃O₂).

Antagonist G, CAS: 115150-59-9, stock: 5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₆₆N₁₂O₆S.

Bovine AVPI1 (Arginine vasopressin-induced protein 1) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

D-Arginine, CAS: 157-06-2, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₄O₂.

D-Arginine 1,1-Dimethylethyl Ester, CAS: 130752-28-2, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂N₄O₂.

D-Arginine Methyl Ester Dihydrochloride, CAS: 78851-84-0, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₈Cl₂N₄O₂.

Desmopressin Acetate, CAS: 62288-83-9, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₆₈N₁₄O₁₄S₂.

Desmopressin acetate trihydrate, CAS: 62357-86-2, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₄N₁₄O₁₂S₂ •  C₂H₄O₂  • 3H ₂O.

Desmopressin Carboxylic Acid Trifluoroacetic Acid Salt, CAS: /, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₆₃N₁₃O₁₄S₂  •  x(C   ₂HF₃O₂).

Desmopressin S-sulfoxide Mixture, CAS: /, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₄N₁₄O₁₃S₂.

Desmopressin-d5, CAS: /, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₉D₅N₁₄O₁₂S₂.

Endo-Gly9a-Desmopressin, CAS: /, stock: 9.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₆₇N₁₅O₁₃S₂.

Endo-Pro7a-Desmopressin, CAS: /, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₇₁N₁₅O₁₃S₂.

Fedovapagon, CAS: 347887-36-9, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄N₄O₃.

Panadoxine P, CAS: 36944-85-1, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀NO₅P.

Fedovapagon-d6, CAS: /, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈D₆N₄O₃.

Human AVP(Vasopressin-neurophysin 2-copeptin) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human AVPI1 (Arginine vasopressin-induced protein 1) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human AVPR1A (Vasopressin V1a receptor) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human AVPR1A(Vasopressin V1a receptor) ELISA Kit (96T), CAS: /, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human AVPR1B (Vasopressin V1b receptor) ELISA Kit (96T), CAS: /, stock: 5.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human AVPR1B(Vasopressin V1b receptor) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Potassium (In Mineral Oil), CAS: 07/09/7440, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  K.

Previtamin D2 (90%), CAS: 21307-05-1, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O.

Mouse Avpi1 (Arginine vasopressin-induced protein 1) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Avpr1a (Vasopressin V1a receptor) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Avpr1b (Vasopressin V1b receptor) ELISA Kit (96T), CAS: /, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Pyridine Hydrochloride, CAS: 628-13-7, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆ClN.

Pyridine-13C2 Hydrochloride, CAS: /, stock: 1.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₆ClN.

Pyridine-15N, CAS: 34322-45-7, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅¹⁵N.

Pyridine-d5, CAS: 7291-22-7, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅D₅N.

Pyridoxal Hydrochloride, CAS: 65-22-5, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀ClNO₃.

Pyridoxal-d3 Hydrochloride, CAS: 1173023-49-8, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₃ClNO₃.

N∼2∼-[(Benzyloxy)carbonyl]asparagine, CAS: 29880-22-6, stock: 7.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₅.

NGly,NGly-Dimethyldesmopressin Trifluoroacetic Acid Salt, CAS: /, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₆₈N₁₄O₁₂S₂  • (C ₂HF₃O₂).

Pyridoxamine-d3 Dihydrochloride, CAS: 1173148-03-2, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁D₃Cl₂N₂O₂.

Nα-Boc-D-Arginine Hydrochloride, CAS: 113712-06-4, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₃ClN₄O₄.

Nα-Cbz-D-arginine, CAS: 6382-93-0, stock: 9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₄O₄.

Pyridoxine Dimer (80%), CAS: 19203-56-6, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O₅.

Nα-Fmoc-D-arginine Hydrochloride, CAS: 214852-44-5, stock: 7.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClN₄O₄.

OPC 21268, CAS: 131631-89-5, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁N₃O₄.

Ornipressin Acetate, CAS: 914453-98-8, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₃N₁₃O₁₂S₂ • x(C ₂H₄O₂).

Ornipressin Diacetate Salt, CAS: /, stock: 7.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₃N₁₃O₁₂S₂ •2(C₂H₄O₂).

Rat Avpi1 (Arginine vasopressin-induced protein 1) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Avpr1a (Vasopressin V1a receptor) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Pyridoxol 5’-Phosphate >90%, CAS: 447-05-2, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂NO₆P.

Rat Avpr1a(Vasopressin V1a receptor) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Avpr1b (Vasopressin V1b receptor) ELISA Kit (96T), CAS: /, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Pyridoxol-d3 5’-Phosphate, CAS: /, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₃NO₆P.

Pyrithioxine Hydrochloride, CAS: 10049-83-9, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁ClN₂O₄S₂.

Rat Avpr1b(Vasopressin V1b receptor) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Pyritinol-d10 Dihydrochloride Hydrate, CAS: 1346601-09-9, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₁₀Cl₂N₂O₅S₂.

Rabbit VB12(Vitamin B12) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

SSR 149415, CAS: 439687-69-1, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂ClN₃O₈S.

TASP 0390325, CAS: 1642187-96-9, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉ClFN₅O₄ • HCl.

Rat Cyp27b1 (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 4.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Vasopressin, CAS: 11000-17-2, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₅N₁₅O₁₂S₂.

Rat Cyp27b1(25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat DBP(Vitamin D Binding Protein) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Vasopressin Acetic Acid Salt, CAS: /, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₅N₁₅O₁₂S₂ • ( C₂H₄O₂).

Vasopressin ELISA Kit (96T), CAS: /, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat DVD/DHVD 3(1,25-dihydroxyvitamin D3) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Proc(Vitamin K-dependent protein C) ELISA Kit (96T), CAS: /, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

[deamino-Cys1, Val4, D-Arg8]-Vasopressin, CAS: 43157-23-9, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₅N₁₃O₁₁S₂.

Rat Pros1(Vitamin K-dependent protein S) ELISA Kit (96T), CAS: /, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat VB 12(vitamin B12) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

[Phenylacetyl1, O-Me-D-Tyr2, Arg6,8, Lys9]-Vasopressin amide, CAS: 148565-73-5, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₈₆N₁₈O₁₂.

Rat Vdr(Vitamin D3 receptor) ELISA Kit (96T), CAS: /, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Retin-15-yl β-D-Glucopyranosiduronic Acid, CAS: 16639-19-3, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₈O₇.

Retinamide, CAS: 20638-84-0, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉NO.

Retinyl Bromide, CAS: 39668-36-5, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉Br.

Rutin, CAS: 153-18-4, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₁₆.

Rutin-d3 (Major), CAS: /, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇D₃O₁₆.

Secalciferol 24-Glucuronide, CAS: 203737-01-3, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₂O₉.

Secalciferol 24-Glucuronide-d6, CAS: /, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₆D₆O₉.

Secalciferol 3-Glucuronide, CAS: 203737-06-8, stock: 2.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₂O₉.

Secalciferol 3-Glucuronide-d6, CAS: /, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₆D₆O₉.

Secalciferol 3-Sulfate Sodium Salt, CAS: /, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₃NaO₆S.

Secalciferol 3-Sulfate-d6 Sodium Salt, CAS: /, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₆NaO₆S.

Succinimide, CAS: 123-56-8, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅NO₂.

Tachysterol (>90%), CAS: 115-61-7, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O.

Tetrahydro-2-[(2R)-1,1,2-trimethyl-3-(phenylsulfonyl)propoxy]-2H-pyran, CAS: 93748-47-1, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆O₄S.

Tetrahydro-2-[(2R)-1,1,2-trimethyl-3-(phenylsulfonyl)propoxy]-2H-pyran-d6, CAS: 1796539-93-9, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₆O₄S.

1-Decarboxyl-1-(bromoacetyl) Norneovardenafil (contains up to 10% 1-Chloroacetyl), CAS: 358388-58-6, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁BrN₄O₃.

Tisocalcitate, CAS: 156965-06-9, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₈O₅.

1-[1-(Ethoxycarbonyl)-2-[(1-oxobutyl)amino]-1-propen-1-yl] Ethanedioic Acid 2-Ethyl Ester, CAS: 68282-25-7, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₇.

2,2’-(Sulfonylbis(6-ethoxybenzene-3-1-diyl))bis(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one), CAS: /, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₈N₈O₆S.

Hydroxy Vandetanib, CAS: 910298-61-2, stock: 7.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄BrFN₄O₃.

2-(2-Ethoxy-4-((4-((4-ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4,4a,5-tetrahydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenyl)sulfonyl)piperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-4a,5-dihydroimidazo[5,1-f][1,2,4]triazin-4(3H)-one, CAS: /, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₀N₁₀O₈S₂.

2-(2-Ethoxyphenyl)-5,7-dimethylimidazo[5,1-f][1,2,4]triazin-4(1H)-one, CAS: 224789-20-2, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₄O₂.

Hydroxy Vandetanib-d4, CAS: 1346598-62-6, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₄BrFN₄O₃.

trans-(±)-6-Allyl-6-azabicyclo[3.1.0]hexan-2-ol, CAS: /, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO.

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, CAS: 224789-21-3, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₄O₂.

2-(2-Ethoxyphenyl)-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazine-4(1H)-thione, CAS: 912576-44-4, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₄OS.

N-Boc-4-piperidinmethanol, CAS: 123855-51-6, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₃.

N-Demethyl Vandetanib, CAS: 338992-12-4, stock: 9.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂BrFN₄O₂.

(2-Chloro-6-ethoxy-4-formylphenoxy)acetic Acid, CAS: 428836-03-7, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁ClO₅.